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ABSTRACT 
 
BACKGROUND: Post-operative urinary retention (POUR) is a post-operative complication that can lead 
to patient dissatisfaction. Ultrasound monitoring of bladder volume can improve patient satisfaction by 
early diagnosis of POUR, therefore limiting the amount of distress experienced by patients and 
preventing adverse effects from prolonged bladder overdistention. Unfortunately ultrasound is currently 
not readily available for this purpose at CHBAH. There was a perception that as much as 30% of post-
operative adult patients at Chris Hani Baragwanath Academic Hospital (CHBAH) considered to be at low 
risk of POUR do develop urinary retention. No research has been done to assess the occurrence of POUR 
at CHBAH.  
OBJECTIVES: The primary objective of this study was to describe the occurrence of POUR in low risk 
patients following elective surgical procedures. The secondary objectives were to determine if the 
occurrence of POUR was influenced by the type of anaesthetic, the age of the patient and the gender of 
the patient. We also described the medications administered in our study sample in the peri-operative 
period.  
METHOD: A prospective, contextual, descriptive study design was used. Adult patients for elective 
surgery in orthopaedic, general surgery, ear nose and throat (ENT), maxillo-facial, plastic or 
ophthalmology who were considered to be at low risk for POUR and consented to participate were 
included. The participants received a general anaesthetic, neuraxial anaesthetic or both. In this study a 
convenience sampling method was used. The researcher approached patients preoperatively to inform 
them about the study and obtain consent, and again 12 – 24 hours following surgery to collect data. 
Data was captured on a data capture sheet. 
In consultation with a biostatistician a sample size of 150 participants was calculated using the program 
nQuery Advisor.  
Data was captured onto a Microsoft Excel spread sheet for analysis. Descriptive statistics were used to 
summarise the participants’ information. 
RESULTS: The study included 156 participants. In this study only one participant had POUR therefore the 
occurrence of POUR was 0.64%. The volume of urine drained on catheterisation in this participant was 
2000 ml. This study could not determine whether the occurrence of POUR was influenced by the type of 
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anaesthetic, the age or the gender of the patient. Systemic opioids were used in the peri-operative 
period in 99.25% of patients who received a general anaesthetic and 95.24% of patients who received 
neuraxial anaesthesia. Non-steroidal anti-inflammatory drugs (NSAIDs) were administered in 88.46% of 
all the participants in the peri-operative period. Of the participants who received a general anaesthetic 
atropine was used in 44.03%, β-agonists in 10.45% and α-agonists in 11.94% of patients. 
CONCLUSION:  
The occurrence of POUR in low risk patients at CHBAH is low. The volume of urine drained at 
catheterisation in the participant who had POUR is alarming. This study could not determine whether 
POUR was influenced by age, gender or type of anaesthetic. Multimodal analgesia is commonly 
prescribed in the peri-operative period at CHBAH. 
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CHAPTER ONE 
OVERVIEW OF THE STUDY 
 
1.1 Introduction 
 
This chapter will serve as an overview of the study and include the following: an introduction and 
background, problem statement, aims and objectives, research assumptions, demarcation of the study 
field, ethical considerations pertaining to the study, research methodology, the significance of the study, 
validity and reliability of this study. 
 
1.2  Background  
 
Post-operative urinary retention (POUR) can cause significant discomfort and distress to the patient. 
Apart from the negative impact on patient satisfaction it may cause acute or long term motility 
abnormalities of the bladder, delayed discharge and increased cost of patient care due to 
catheterisation, treatment of urinary tract infection and prolonged hospital stay. (1-7) 
The occurrence of POUR varies widely in the literature and has been documented to range from <1% to 
>50%. This wide variation may be attributed to the various definitions used in studies. There is no 
standardised time to voiding or urine volume for the diagnosis of POUR to be made. The definitions for 
POUR used in the literature were often at the researchers own discretion. (1, 4, 8-10) No literature 
pertaining to the occurrence of POUR in South Africa could be identified.  
Several factors may contribute to POUR. Although increasing age is associated with POUR (4, 10-14), a 
higher incidence of POUR in men older than 50 years (10, 12) may be attributed to common prostate 
pathology especially benign prostate hyperplasia (BPH) (8, 15).  A history of lower urinary tract 
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pathology or abnormal voiding is considered to be a risk factor for POUR (8, 10, 12, 16, 17). POUR is a 
well-known documented complication of neuraxial blocks (4, 11, 18-20) but the contribution of systemic 
medication used during general anaesthesia and analgesia is not well documented. The increased 
amount of intravenous fluid and opioid use during prolonged anaesthesia and surgery are thought to 
contribute to the higher incidence of POUR documented (4, 14). Different ladder sizes and bladder 
capacities among patients of different ethnic groups may also play a role (5). 
Surgeries considered to be high risk for POUR include: inguinal hernia repair, anorectal, perineal, and 
emergency surgery (1, 10, 11, 14, 18). Procedures involving manipulation of the bladder or 
instrumentation of the lower urinary tract may cause inflammation and edema predisposing patients to 
POUR (15).  
The diagnosis of POUR can be made by clinical recognition, catheterisation or ultrasound. Clinical 
recognition of POUR is not reliable and depend on the skills and experience of the nursing staff (1). 
Palpation and percussion of the lower abdomen may be very uncomfortable or painful to the patient in 
the post-operative period and a full bladder may easily be missed especially in the obese or elderly (2). It 
has been documented that patients with POUR may not be aware of a full bladder after neuraxial block 
or general anaesthesia (1, 4) and patients who are able to void spontaneously may have a significant 
residual volume (1, 20), therefore a high index of suspicion should be maintained. 
Diagnosis of POUR by catheterisation is invasive and embarrassing to the patient (6). Unnecessary 
catheterisation should be avoided as it predisposes patients to urinary tract infections, trauma, urethral 
strictures and prolonged hospital stay (17). No consensus has been reached whether in-out or indwelling 
urinary catheters are more beneficial (6, 15).  
Urinary catheterisation is not without risk. Reinforcement of non-invasive management of POUR and the 
administration of an α-adrenergic antagonist or cholinergic medication may aid voiding and prevent 
unnecessary catheterisation (2, 10, 15, 21, 22). 
Ultrasound has a high sensitivity and specificity for the diagnosis of POUR. It is a non-invasive and cost-
effective measuring tool that have gained popularity (5, 9, 18, 23). It has been suggested that ultrasound 
should be used routinely in the post-operative period to monitor patients at high risk of POUR to 
facilitate early diagnosis (1, 4, 11). Unfortunately the initial cost to obtain ultrasound is expensive and it 
is not readily available in all hospitals. 
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Awareness of POUR and its adverse effects may prompt health care providers to identify patients at risk 
and implement prevention strategies such as multimodal analgesia, careful consideration of the type of 
anaesthetic and medication used, encourage voiding prior to surgery and judicious fluid administration 
(1, 11, 15, 19, 24, 25). 
The occurrence of POUR at CHBAH had never been documented to our knowledge. It was possible that 
urinary retention was only recognised once patients experience discomfort, pain or other adverse 
effects of bladder distension especially the patient at low risk of POUR that may not be monitored as 
closely as the patient at high risk. Patient satisfaction is not routinely documented and a high occurrence 
among patients at low risk of POUR may increase awareness of POUR and indicate the need for a 
management protocol to be developed for post-operative care at CHBAH with the available resources. 
 
1.3  Problem statement 
 
Urinary retention is a commonly underdiagnosed post-operative complication that results in patient 
discomfort and possible permanent damage to the lower urinary tract. Reliable early detection of POUR 
is possible with an ultrasound of the bladder. This method of detecting a full bladder is not readily 
available for post-operative patients at CHBAH.  
There was a perception that as much as 30% of post-operative adult patients at Chris Hani Baragwanath 
Academic Hospital (CHBAH) considered to be at low risk of POUR do develop urinary retention. Patients 
known to be at high risk of POUR are usually monitored closely and POUR can be diagnosed timeously. 
Voiding may not be considered to be as important as other monitored parameters in the patient at low 
risk of POUR and may predispose patients to late diagnosis in the post-operative wards. As the 
occurrence of POUR at CHBAH was unknown the researcher was approached to conduct the study.  
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1.4  Aim 
 
The aim of this study was to describe the occurrence of POUR in adult patients at low risk of POUR who 
presented for elective surgical procedures at CHBAH and to determine if this was influenced by age, 
gender or type of anaesthetic received.   
 
1.5 Objectives 
 
The primary objective of this study was to describe the occurrence of POUR in low risk patients following 
elective surgical procedures.  
The secondary objectives of this study were to: 
• determine if the occurrence of POUR was influenced by: 
• the type of anaesthetic  
• the age of the patient  
• the gender of the patient 
• describe the medications administered in the peri-operative period. 
. 
1.6 Research assumptions and definitions 
 
The following definitions were used in this study:  
Adult: any patient 18 years or older. 
 
Post-operative urinary retention (POUR): is the inability to empty the bladder without non-invasive 
or invasive interventions in the post-operative period. 
Post-operative period: the post-operative period was considered to start from arrival in the 
recovery room to 24 hours after the end of anaesthesia.  
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High risk of POUR: patients considered to be at high risk of POUR included patients who had 
anorectal surgery, inguinal hernia repair, pelvic or abdominal surgery, previous surgery to the 
urinary tract, patients with a history of abnormal voiding or known prostate pathology, urinary tract 
infection in the seven days prior to surgery or previous POUR. 
Low risk of POUR:  if none of the above factors were evident patients were considered to be at low 
risk of POUR.    
Non-invasive management of POUR: this referred to interventions done by nursing staff that 
encouraged voiding but which excluded catheterisation. 
Invasive management of POUR: referred to catheterisation which may have been in-out or 
indwelling. 
Occurrence: the term occurrence is used in this study as the biostatistician consulted was of the 
opinion that although the sample size was appropriate for the study, it was not adequate to 
describe the prevalence of POUR from epidemiological perspective. However, incidence and 
prevalence will be used in the discussion of the literature when used by the authors.  
 
1.7 Demarcation of study field 
 
The study was conducted in the post-operative wards of the CHBAH in the following surgical disciplines: 
orthopaedic; general surgery; ear nose and throat (ENT); maxillo-facial, plastics and ophthalmology. 
CHBAH is a 3 200 bed tertiary hospital in Soweto affiliated to the University of the Witwatersrand, 
Johannesburg (26).  Annually more than 43 657 surgeries are performed in the J.D. Allen theatre 
complexes of the hospital (27).  
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1.8 Ethical considerations 
 
Permission to conduct the study was sought from the relevant authorities. 
Patients were invited to take part in the study. An information letter (Appendix A) was given to those 
who agreed to participate and informed written consent (Appendix B) was obtained. Anonymity and 
confidentiality of participants was maintained. 
The study was conducted according to the principles of the Declaration of Helsinki (28) and the South 
African Good Clinical Practice Guidelines (29).   
 
1.9  Research methodology 
 
1.9.1 Research design 
 
A prospective, contextual, descriptive study design was used. 
 
1.9.2 Study population 
 
The population for this study was adult patients in the post-operative wards who were at low risk for 
POUR and received either general anaesthesia or a neuraxial block during their elective surgical 
procedure. 
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1.9.3 Study sample 
 
In consultation with a biostatistician a sample size of 150 participants was calculated using the program 
nQuery Advisor. In this study a convenience sampling method was used. Inclusion and exclusion criteria 
were used to select participants suitable for the study. 
 
 
1.9.4 Data collection 
 
Potential participants from the specified surgical disciplines were identified from the theatre booking 
lists in the CHBAH J.D. Allen Theatre Complex the day before surgery or on the day of surgery but before 
the patient arrived in theatre from the ward. 
 
The participants were approached in their respective wards before surgery. An information letter 
(Appendix A) was given to each patient and the researcher explained the purpose of the study. If the 
patient agreed to participate in the study, written informed consent (Appendix B) was obtained. 
 
The researcher approached participants 12 – 24 hours following surgery. Data collected from the 
participants was captured on a data capture sheet (Appendix C). 
 
1.9.5 Data analysis 
 
Data was captured onto a Microsoft Excel spread sheet for analysis. Descriptive statistics were used to 
summarise the participants’ information. 
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1.10 Significance of the study 
 
A strong association has been documented between patient dissatisfaction and post-operative 
complications including post-operative urinary retention (POUR). Prevention and early management of 
post-operative complications may lead to an improvement in quality of care and patient satisfaction. 
(30) 
The occurrence of POUR at the CHBAH was unknown. If this study demonstrated a significant proportion 
of the patients at low risk for POUR presenting for surgery at CHBAH were catheterised, it would 
improve awareness of POUR.  Patient comfort and safety may then be improved by early intervention in 
low risk patients.  
1.11 Validity and reliability of study 
 
Measures were put in place to ensure the validity and reliability of the study. 
 
1.12 Project outline 
 
This report includes the following chapters: 
• Chapter 1: Overview of the study 
• Chapter 2: Literature review  
• Chapter 3: Research methodology 
• Chapter 4: Results and discussion 
• Chapter 5: Summary, limitations, recommendations and conclusion. 
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1.13 Summary 
 
In this chapter a brief overview was given on the study that was done and included an introduction and 
background, problem statement, aims and objectives, research assumptions, demarcation of the study 
field, ethical considerations pertaining to the study, research methodology, the significance of the study, 
validity and reliability and a project outline. 
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CHAPTER TWO 
LITERATURE REVIEW 
 
2.1 Introduction  
 
This chapter will review the literature concerning POUR. It includes patient satisfaction and safety, the 
definition of POUR, an overview of the applicable anatomy, physiology and pharmacophysiology, the 
occurrence of POUR, the pathophysiology involved in urinary retention, risk factors associated with 
POUR, the diagnosis of POUR and management options for POUR.  
 
2.2 Patient satisfaction and safety 
 
Patient satisfaction is a complex entity and incorporates the patient’s values, perceptions, attitude, 
culture and emotions. The patient judges care against a standard of care expected. When a discrepancy 
exists between the patient’s expectations and the actual care received, dissatisfaction may be the 
consequence. (31) Providing adequate information to patients may bridge this gap and result in 
improved patient satisfaction. (32) 
 
A strong association has been documented between patient dissatisfaction and post-operative 
complications including post-operative urinary retention (POUR). Prevention and early management of 
post-operative complications may lead to an improvement in quality of care and patient satisfaction. 
(30) The care provided when a post-operative complication is present may have greater impact on 
patient satisfaction than the complication itself (32). 
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Literature on factors associated with patient dissatisfaction is limited globally and the research available 
may not be generalisable to other populations and health care settings. To our knowledge no research 
has been conducted in the South African population to assess patient satisfaction and the influence of 
POUR.  
 
2.3 Definition of post-operative urinary retention (POUR) 
 
Urinary retention is defined as the inability to completely or partially empty the bladder (33). 
The normal bladder capacity is considered to be 400-600 ml for an average adult without pathology of 
the lower urinary system (3, 4, 6). The possibility that bladder sizes may differ among ethnic groups (5, 
34) may contribute to the wide range.  
Different types of bladder capacity are described in the literature namely anaesthetic bladder capacity, 
functional bladder capacity and cystometric bladder capacity. Anaesthetic bladder capacity refers to the 
volume of fluid that can be introduced into the bladder during a cystoscopic procedure while a patient is 
under anaesthesia. Compared to the other types of bladder capacity, the volume that can be infused 
into the bladder is much greater. Functional bladder capacity is the volume of urine in the bladder prior 
to voluntary voiding and is based on the volumes of urine recorded in a diary by the patient. There tends 
to be great variation among individuals because the decision to voluntarily void is influenced by multiple 
factors. Cystometric bladder capacity refers to the volume in the bladder at the end of a filing 
cystometrogram. (34)  
 
2.4 Overview of anatomy, physiology and pharmacophysiology 
 
2.4.1 Brief overview of anatomy and physiology of the lower urinary tract 
 
The main functions of the bladder are to store and excrete urine. The bladder wall is very compliant, 
therefore, significant volumes of urine can be stored (3).   
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The bladder consists mainly of smooth muscle, collagen and elastin (3). The smooth muscle of the 
bladder consists of three layers which are arranged in longitudinal, circular and spiral bundles. The 
circular muscle is referred to as the detrusor muscle. (35) In order to maintain the capacity of the 
bladder, the smooth muscle of the bladder is maintained at a steady tone. Various factors may influence 
bladder tone including autonomic activity, hormones, local metabolites, temperature, response to 
stretch and locally secreted agents (e.g. nitric oxide). (3) The smooth muscle of the bladder has an 
intrinsic ability to contract when stretch receptors in the bladder wall are stimulated. Under normal 
conditions, the threshold for bladder contraction initiated by neural stimulation is lower than that for 
the smooth muscle itself. The intrinsic ability of the smooth muscle to contract has no function in 
normal bladder emptying, but in pathological conditions affecting nerve supply to the bladder, may 
result in various motility disorders of the bladder. (3, 35) 
 The internal sphincter (Figure 1) is formed by the smooth muscle of the bladder that extends to 
surround the upper part of the urethra.  The control of the internal sphincter is involuntary. In the 
female, the internal urethral sphincter is tonically contracted to prevent leaking of urine. The role of the 
internal sphincter in the male is to prevent reflux of semen during ejaculation. It has no role during 
micturition. The sympathetic nervous system causes bladder contraction during ejaculation, thus 
preventing reflux of semen into the bladder. The external sphincter is formed by the pelvic floor 
muscles. In contrast to the internal sphincter, the external sphincter consists of skeletal muscles and is 
under voluntary control (Figure 1). Micturition can be delayed by the learned ability to keep the external 
urethral sphincter contracted. (3, 35) 
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Figure 2.1 The Lower Urinary Tract (36) 1 
 
Regular peristalsis in the ureters facilitate filling of the bladder at a slow rate (35). With reference to 
Laplace’s law, the tension in the bladder wall during filling is directly proportional to the intravesical 
pressure and the size of the bladder. The intravesical pressure remains relatively constant during filling 
due to the compliance of the bladder wall. An increase in the intravesical pressure occurs when bladder 
capacity is reached. The tension in the bladder wall increases as the bladder expands, and increases 
even further when bladder capacity is reached. The sensation of a full bladder is experienced when 
increased tension in the bladder wall activates bladder afferent nerves. The first urge to void in an 
average adult is experienced at a bladder volume of 150 ml (3, 4, 6, 21, 35), whereas a marked sense of 
fullness of the bladder is experienced at a volume of 300-400 ml (3, 4, 6, 21, 35, 37) 
 
2.4.2 The nervous system and micturition 
 
Voiding is triggered by reflex activity, but is subject to voluntary facilitation or inhibition. Sustained 
synchronous contraction of the smooth muscle of the bladder is required for effective voiding. (3, 35)  
Control of the lower urinary tract is achieved by complex interaction of different components of the 
nervous system.  Excretion of urine requires coordinated smooth muscle activity of the bladder and 
urethra. (3, 35) To achieve this coordination, reflex pathways in the brain and spinal cord function as on-
off switching circuits, with various feedback mechanisms. (3) 
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Parasympathetic supply to the bladder arises at the sacral level of the spinal cord (S2, S3, S4). Activation 
of the parasympathetic nerves results in detrusor muscle contraction and relaxation of the urethra (3, 
35). The effects of the parasympathetic nervous system on the lower urinary tract are achieved by 
acetylcholine release from neurons, nitric oxide release (inhibitory transmitter) and removal of 
excitatory stimulation (3). Efferent fibres of the parasympathetic supply of the lower urinary tract travel 
in the pelvic nerves. The parasympathetic nervous system plays a vital role in micturition. When the 
parasympathetic nerve supply to the lower urinary tract is removed, the bladder becomes distended 
and hypotonic. (3, 35) 
Sympathetic nerve supply arises from the thoracolumbar spinal cord (T10-L3) (3, 38) . Postganglionic 
fibres travel through the hypogastric nerve to the detrusor muscle and the internal urethral sphincter. In 
contrast to parasympathetic activation, the sympathetic nervous system plays no role in micturition. 
Stimulation inhibits bladder contraction and excites the bladder outlet and urethra. (3, 35) 
The external urethral sphincter is excited by the pudendal nerves (S2, S3, S4), which contains sacral 
somatic pathways. The somatic afferent pathways can inhibit voiding by activation of afferents from 
various sites. (3, 35) 
The micturition reflex is initiated by activation of stretch receptors located in the bladder wall. 
Micturition can be involuntary or voluntary. The afferent and efferent fibres of the micturition reflex 
travel in the pelvic nerves, and integration takes place in the sacral spinal cord. At bladder volumes of 
more than 150 ml in a normal adult, the stretch receptors in the bladder wall are stimulated. This results 
in activation of the afferent pathways. Impulses travel through the afferent fibres in the pelvic nerves to 
the sacral spinal cord. The parasympathetic pathway to the lower urinary tract is stimulated and the 
sympathetic pathway is inhibited. (3, 35) The threshold of the voiding reflex can be altered by 
facilitatory centres in the pons and posterior hypothalamus, or inhibitory centres in the midbrain.  
Voluntary control is achieved by suppressing the micturition reflex through connections between the 
frontal cortex, the hypothalamus, the paracentral lobule and the brainstem. With pathological 
conditions involving these connections, inhibition of the micturition reflex is lost and voiding occurs 
involuntarily. Voluntary relaxation of the external urethral sphincter is achieved by inhibition of the 
somatic motor neurons. Bladder contraction during voiding is intensified by positive feedback loops 
involving central mechanisms. These central mechanisms are stimulated by reflexes which are initiated 
by the stretch receptors. (3) 
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2.4.3 The role of the urothelium 
 
The urothelium has similar properties to nociceptors and mechanoreceptors. In response to mechanical 
and chemical stimulation, the urothelial cells can release nitric oxide (NO), adenosine triphosphate (ATP) 
and Substance P which can have excitatory or inhibitory actions on the afferent nerves that are in close 
proximity or in the urothelium. (3) The role of NO in the urothelium still needs to be investigated. NO is 
released especially during inflammation (3). ATP is released in response to stretch and activate 
suburothelial bladder afferents (3). 
Prostaglandins released from the urothelium have two possible functions, regulation of detrusor muscle 
activity and cytoprotection of the urothelium (3). Prostaglandin synthesis increases during inflammation, 
trauma and overdistension of the bladder (39). 
Muscarinic receptors are abundant in the urothelium. The urothelium constantly releases a basal 
amount of acetylcholine resulting in modulation of afferent nerve and smooth muscle activity. The basal 
release of acetylcholine increases with stretch and aging.  (3) 
 
2.4.4 Pharmacophysiology  
 
In order to understand the influences of various medications on the lower urinary system an overview of 
pharmacophysiology will follow. 
 
2.4.4.1 Peripheral pharmacophysiology 
 
Muscarinic mechanisms 
In the lower urinary tract, muscarinic receptors are located in the bladder itself and prejunctionally on 
cholinergic nerve terminals in the bladder. Stimulation of the muscarinic receptors in the bladder result 
in an increase in intracellular calcium, which leads to detrusor contraction. Calcium ions move across the 
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membrane through nifedipine-sensitive L-type calcium channels, thus nifedipine, a calcium channel 
blocker, can suppress muscarinic-mediated detrusor contraction.  The muscarinic receptors are also 
involved in an amplification mechanism to ensure complete emptying of the bladder. Nicotinic 
transmission is modulated in the central nervous system by inhibitory and facilitatory muscarinic 
receptors. Studies done on mice indicated a possible gender difference in the micturition mechanism. 
Atropine, an anticholinergic drug, can completely abolish the contractile responses of the detrusor 
muscle. (3) 
 Purinergic mechanisms 
ATP acts on two families of purinergic receptors, an ion channel family and a G protein-coupled receptor 
family. In the human bladder, the ion channel receptors predominate. These ion channel receptors may 
upregulate in bladder obstruction. Adenosine may depress bladder contraction stimulated by 
parasympathetic activity. (3) 
Adrenergic mechanisms 
Β-Adrenergic mechanisms 
The human detrusor muscle has β₂- and β₃-receptors. Stimulation of these receptors causes 
accumulation of cyclic AMP (cAMP) which results in direct detrusor relaxation. It is mainly the β₃-
receptors that are responsible for the relaxation of the detrusor muscle. (3) 
α-Adrenergic mechanisms 
In the normal bladder α-adrenergic stimulation is not prominent. In pathologic conditions the density of 
the α-adrenergic receptors may increase (3). 
α-Adrenergic mechanisms play an important role in urethral tone and intraurethral pressure. Resting 
urethral tone is maintained mainly by α1-receptors. The urethra has α1- and α₂-receptors with the α1-
receptors being more prominent. α-Agonists will increase intraurethral pressure and promote urine 
storage, while α-antagonists will promote the release of urine. (3) 
Nitric Oxide (NO) 
NO induced relaxation of smooth muscle is due to increased cyclic guanosine monophosphate (cGMP). 
NO is considered to be an inhibitory neurotransmitter and result in relaxation of urethral smooth 
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muscle. NO may have NMDA-receptor dependent effects. At spinal level, NO has an excitatory effect on 
the micturition reflex. Locally on the bladder, NO is considered to have an inhibitory effect. This is 
mediated by modulation of bladder afferent activity. Studies in rats implicated possible gender 
differences in parasympathetic and NO-mediated pathways in the human urethra. (3) 
Afferent neuropeptides 
Noxious stimulation result in the release of various peptides from the C-fibre bladder afferents. These 
peptides contribute to the inflammatory response in the bladder and may alter smooth muscle activity. 
The peptides also act as transmitters at the afferent terminals in the spinal cord. (3) 
Stimulation of tachykinin (small peptides) receptors in the spinal cord, activate the opioid mechanisms. 
The micturition reflex can be inhibited by the activation of opioid mechanisms in the spinal cord. (3) 
Prostanoids 
Prostaglandins and thromboxanes are manufactured throughout the lower urinary tract and are 
involved in contractility, inflammation and neurotransmission. Prostaglandins are considered to have a 
modulatory role, some by affecting neural release of transmitters and others by inhibiting 
acetylcholinesterase. Indomethacin inhibits prostaglandin synthesis. (3) 
 
2.4.4.2 Central pharmacophysiology 
 
Spinal cord 
Spinal reflex pathways involved in control of the bladder and sphincter functions use the glutamatergic 
transmitter mechanisms namely N-methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-5-
methylisoxazole-4-propionate (AMPA). Glutamate plays a role as an excitatory transmitter in the 
afferent limb of the micturition pathway. (3) 
In the spinal cord, α-adrenoceptors can mediate inhibitory or excitatory effects on the lower urinary 
tract. The afferent pathways of the micturition reflex receive inhibitory input from noradrenergic 
systems, while the efferent pathways of the micturition reflex receive excitatory input from 
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noradrenergic systems. Lumbar sympathetic outflow is controlled by α1-excitatory and α2-inhibitory 
mechanisms. (3) 
The reflex pathways in the spinal cord are inhibited by opioid peptides. In the spinal cord of the cat 
inhibition of reflex bladder activity is mediated by δ-receptors while inhibition of sphincter activity is 
mediated by κ-receptors.  In the rat, inhibition of the bladder is mediated by δ- and µ-receptors. 
Pontine micturition centre and supraspinal 
Glutamate, Gamma-aminobutyric acid (GABA), Dopamine, serotonin as well as cholinergic mechanisms 
are involved in the pontine micturition centre and supraspinal pathways. µ- and δ-receptors mediate 
opioid inhibitory effects and increase bladder capacity. These effects can be blocked by naloxone. 
Naloxone in itself facilitates the micturition reflex. (3) 
 
2.4.4.3 Medication implicated in post-operative urinary retention (POUR) 
 
Literature on medication that may affect the lower urinary tract is limited. A brief overview on the 
mechanism of action and the possible effects on the lower urinary tract of various medication 
commonly used peri-operatively will follow.  
 
Anticholinergics 
Mechanism of action: competitive antagonists of muscarinic receptors, therefore a reduced response to 
cholinergic stimulation. (3, 40) 
Effects on the lower urinary system: The anticholinergics may decrease bladder tone and increase the 
tone of the sphincter, thus patients who receive these medications may be at a higher risk for POUR. 
(15, 40-42) Examples of commonly used anticholinergics in anaesthetic practice are atropine and 
glycopyrrolate. 
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Other medications with anticholinergic effects 
• Antipsychotic agents e.g. phenothiazines, thioxanthenes 
• Antidepressants e. g. tricyclic antidepressants, tetracyclic antideppressants 
• Antiarrythmic agents (class I) e. g. disopyramide, flecainide  
• Antispasmodic agents e. g. hyoscine butylbromide 
• Antiparkinsonian agents e. g. biperiden, dexetimide, amantadine  
• H₁-receptor antagonist e. g. first generation: diphenhydramine, promethazine and  second 
generation: loratidine 
• Inhaled anticholinergics e. g. ipratropium. (42, 43)    
Calcium antagonists 
Mechanism of action: bind to calcium channels, therefore it prevent the calcium influx which would 
normally lead to muscle contraction (40). 
Effects on the lower urinary tract: direct smooth muscle relaxation and decreased contractility of 
smooth muscle (3, 42), may also have anticholinergic properties (3). Examples are diltiazem, nifedipine 
and verapamil. 
Non-Steroidal Anti-inflammatory Drugs (NSAIDs) 
Mechanism of action: selective or non-selective inhibition of the enzyme(s) which catalyze the synthesis 
of prostaglandin from arachnidonic acid, namely cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-
2). (40) 
Effects on the lower urinary system: may promote relaxation of the bladder and decreases inherent 
activity of the bladder smooth muscle (3).  The highest risk for acute urinary retention associated with 
NSAIDs, are among first time users of NSAIDs or patients who use the highest recommended dose (39, 
42).  An example is Flurbiprofen. 
β-Adrenergic agonists 
Mechanism of action: Selective or non-selective stimulation of β-receptors (40). 
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Effects on lower urinary system: Sympathetic stimulation through β-receptors result in bladder 
relaxation (3). Examples are Isoproterenol (non-selective) and Terbutaline (selective β2) 
α-Adrenergic agonists 
Mechanism of action: Selective or non-selective stimulation of α-receptors (40). 
Effects on the lower urinary system: Increase urethral tone (3, 42) by binding to the α₁ᴀ∕ᴅ-receptors 
(42). Examples are phenylephrine (α1-selective) and clonidine (α2-selective) 
Some medications commonly used in anaesthesia have both α- and β-agonist effects e.g. Ephedrine, 
Adrenaline (40). 
 
Table 2.1 General anaesthetic agents 1 
General Anaesthetic Agents Mechanism of Action 
Propofol Interact with GABAA receptor. (40) 
 
Etomidate Relative selective action on GABAA receptor (40) 
Benzodiazepines Enhance the affinity of GABA receptors for GABA.(40) 
 
Barbiturates Bind to GABA receptor. 
Decrease rate of dissociation of GABA from the GABA receptor. 
Also have effects at glutamate receptors, adenosine receptors and 
nicotinic acetylcholine receptors. (40) 
Ketamine Noncompetitive binding to the NMDA receptors.  
May also have effects on the opioid receptors, monoaminergic 
receptors, muscarinic receptors, voltage-sensitive sodium and L-
type calcium channels.  
Weak action on GABAA receptors. (40) 
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Effects of general anaesthetic agents on the lower urinary tract: Fan (8) suggested that general 
anaesthetic agents cause dysfunction of the autonomic nervous system which results in bladder 
function abnormalities. Benzodiazepines may either be a causative or preventive factor related to 
urinary retention. The mechanisms are believed to be related to muscle relaxation or anxiolytic and 
skeletal muscle relaxation respectively. (42) Clinical evidence of the effects on the lower urinary tract of 
the general anaesthetic  agents are limited. When considering the normal physiology of micturition and 
the receptors involved in the mechanism of action of these agents, there is clearly a possibility of an 
increased risk for abnormal voiding.  
Opioids 
Mechanism of action: Agonist activity at opioid receptors. Receptors may be central, with receptors 
mainly pre- and postsynaptically in the brainstem and the spinal cord, or peripherally on various tissues. 
(40) 
Effects on lower urinary system: neuraxial administered opioids result in detrusor relaxation and an 
increase in maximum bladder capacity. The agonistic activity on sacrally located opioid receptors may 
cause parasympathetic inhibition, which leads to urinary retention. According to Stoelting (40) urinary 
retention caused by neuraxial opioids is not dose-dependent or related to systemic absorption (40). In 
contrast, Kuipers et al. (25) stated the abnormal lower urinary tract function after intrathecal morphine 
and sufentanil was related to the pharmacokinetics of the drug and were dose-dependent (25). 
Systemically administered morphine and other opioids may decrease parasympathetic tone (41, 42) and 
lead to an increase detrusor muscle tone and the sphincter tone, contributing to an increased risk of 
urinary retention (40, 42, 44). 
Local anaesthetic agents 
Mechanism of action: prevents threshold potential being reached in nerve membranes by blocking 
sodium channels.  
Effects on the lower urinary system: Urinary retention is mainly due to the chemical  inhibition of nerve 
impulses, thereby blocking the normal micturition reflex pathways (40). 
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2.5 Occurrence of POUR 
 
The occurrence of POUR in the literature varies widely. One of the most striking factors contributing to 
this is the various definitions and diagnostic criteria used in the studies. Multiple factors may also 
influence the occurrence of post-operative urinary retention. The risk factors are controversial  (1, 4, 8, 
11, 18, 19, 24, 37)  and will be discussed  later. Studies done were not standardised and therefore it is 
difficult to compare results. The occurrence is documented between <1 to >50% (1, 4, 7-10, 42, 45, 46). 
The variety of occurrences documented will be illustrated with reference to the various definitions used 
for POUR and other factors which may influence occurrence.  
Stallard (41) defined urinary retention as an inability to void >12 hours after induction of anaesthesia 
and >500 ml of urine drained at first catheterisation. Patients were also diagnosed with POUR if they 
complained of painful urinary retention or when the bladder was palpable. The incidence of POUR in this 
study was 6%. (41)  
Tammela (10) documented an incidence of 3.8% in a study where the diagnosis of POUR were made 
when patients have not voided several hours after the end of surgery and the patient experienced 
discomfort due to a full bladder or had a palpable bladder. The number of hours post-operative was not 
specified. Non-invasive measures were attempted before catheterisation which was not done in the 
study by Stallard (41). (10) 
In a study by Bhattacharya (19) patients were catheterised if they did not pass urine within three hours 
post-operatively or when they complained of urinary retention. The incidence of POUR in this study for 
the group of patients who received spinal anaesthesia was 16%. The incidence may be falsely high since 
only three hours was allowed for patients to void post-operatively. Pavlin (18) documented that 
unnecessary catheterisations would have been 50% if patients were expected to void within two to 
three hours instead of catheterisation at bladder volumes of >600ml measured with an ultrasound 
associated with an inability to void (18).  
Time alone is a poor indicator of urinary retention. When time is used as a diagnostic criteria, there may 
be an under- or overdiagnosis of POUR. Tammela (10) documented the time from end of surgery to the 
time of first catheterisation. At the time when patients were catheterised they had bladder volumes 
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exceeding the normal bladder capacity and some even had overflow incontinence (10), possibly 
indicating a late diagnosis of urinary retention.   
The ultrasound diagnosis of urinary retention is progressively gaining popularity. Since the range for 
normal bladder capacity is wide, there are inconsistencies with the volumes used as cut-off points for 
the ultrasound diagnosis of urinary retention. Therefore, the criteria to diagnose urinary retention based 
on ultrasound findings needs to be clearly defined. 
Pavlin (1), Keita (14) and Kreutziger (13) used the same diagnostic criteria for POUR. In these studies 
POUR was diagnosed when a bladder volume of >600 ml on ultrasound was associated with an inability 
to void. The incidence of POUR was documented as 0.5% in patients at low risk, 5% in patients at high 
risk and 25% re-retention after in-out catheterisation in the study by Pavlin (1). Keita (14) did not 
distinguish low risk or high risk groups and included patients who had orthopaedic, vascular, thoracic, 
abdominal and urologic surgery. Keita (14) allowed the patients with a bladder volume of > 600 ml 30 
minutes of privacy in which they attempted to void spontaneously. The patients were allowed to sit but 
not stand during the 30 minutes. The incidence documented was 16% from the total study sample. (14) 
Kreutziger (13) investigated 2% prilocaine as a possible intrathecal local anaesthetic for ambulatory 
surgery and the incidence was documented to be 23%.  
A study by Hansen (11) allowed patients with a bladder volume ≥ 400 ml to attempt to void 
spontaneously within 1 hour before catheterisation was done. The incidence of POUR was 10.7% but 
this study excluded patients at increased risk for POUR including those with epidural analgesia post-
operatively, abdominal surgery, hip and knee arthroplasty. (11) 
Feliciano (6) defined POUR as a bladder volume of >500 ml on ultrasound associated with an inability to 
void within 30 minutes. He reported an incidence of 44.1% but his study sample consisted only of 
patients who had spinal anaesthesia. (6)  
 
2.6 Pathophysiology involved in urinary retention 
 
Several pathophysiological processes may be involved in the development of POUR. Often more than 
one pathophysiological process contributes to POUR.  
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2.6.1 Medication and anaesthetic technique 
 
The medication thought to affect the lower urinary tract and possibly contribute to POUR was discussed 
above. During a general or neuraxial anaesthetia a variety of the medications thought to contribute to 
POUR may be used. Not only the medications, but also the mode of delivery and anaesthetic technique 
may play a significant role in POUR. 
After spinal anaesthesia, urodynamic changes may last for hours. Even when motor block have 
regressed completely, urodynamic changes may persist. The duration of urodynamic changes depend on 
the physicochemical properties of the local anaesthetic used. (24)  
Detrusor block lasts significantly longer after spinal anaesthesia with bupivacaine when compared to 
lignocaine. Bladder volumes accumulated during the time of detrusor block after spinal anaesthesia with 
bupivacaine, were significantly higher than the measured cystometric capacity of the bladder before 
spinal anaesthesia. The urge to void after spinal anaesthesia disappears quickly, and spontaneous 
voiding is only regained once the sensory level has regressed to S3. (24) 
Unilateral spinal anaesthesia may theoretically have a decreased incidence of POUR since pathways 
controlling bladder contraction will be affected only partially (47). In a study done by Voelckel (47), 
there was no statistically significant difference between patients who received a unilateral spinal 
anaesthesia compared to patients who received bilateral spinal anaesthesia for knee surgery. The 
incidence of POUR was 30% and 35% for the two groups respectively. (47) An explanation may be that 
uncoordinated contraction may result in bulging of the compliant areas of the bladder that are not 
contracting (3). 
Selective pudendal nerve block may be an appropriate alternative to spinal anaesthesia for 
haemorrhoidectomy. The incidence of urinary retention after haemorrhoidectomy with pudendal block 
was significantly decreased (15). 
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2.6.2 Inflammatory and infective 
 
Urinary retention may result from edema of the lower urinary tract or inflammation around the sacral 
nerves (15). This may explain the increased incidence of POUR after pelvic surgery. 
 
2.6.3 Neurologic 
 
Any disruption of the neurologic pathways involved in micturition may lead to abnormal voiding (15). 
Local anaesthetic agents injected either intrathecally or as an epidural may interrupt these pathways 
chemically. Pathology involving the neurologic pathways or disrupting normal neurological physiology  
like stroke, multiple sclerosis, neuropathy and spinal pathology may also cause abnormal voiding (10, 15, 
48, 49). 
  
2.6.4 Obstructive 
 
A history of abnormal voiding preoperatively is a predisposing factor to POUR (10). Benign prostatic 
hyperplasia (BPH) is the most common obstructive cause of the lower urinary tract (15) and has been 
shown to be significantly associated with POUR (8, 13). Two mechanisms cause bladder outlet 
obstruction in BPH: 1. the enlarged prostate impinges on the urethra 2. increased α-adrenergic tone. 
Other possible causes of abnormal voiding include previous surgery or trauma on the pelvis or lower 
urinary tract, previous prostatitis and previous urinary tract infection (10). In the female, pregnancy and 
prolapse of the bladder, uterus or rectum may cause obstruction. Pelvic masses and intravesical 
hematoma are also possibilities. (15)  
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2.6.5 Other  
 
Reflex of the bladder sphincter may be caused by pain, anxiety, bladder manipulation and 
catheterisation. (9, 10) 
 
2.7 Risk factors associated with POUR 
 
Multiple studies have been conducted with the aim to identify risk factors which predispose patients to 
the development of post-operative urinary retention (4, 6, 10-14).  Early identification of patients at risk 
could prevent bladder overdistension.  
 
2.7.1 Age 
 
A correlation between the incidence of POUR and increasing age was shown in multiple studies, with 
patients 50 years and older at increased risk (4, 10-14, 50). Lamonerie (4) documented an odds ratio of 
2.11 with multivariate analysis for patients older than 60 years (95% confidence interval 1.01-4.38)(4) 
whereas Hansen (11) documented an odds ratio of 1.53 for patients older than 50 years. The association 
of POUR and age may be due to degenerative changes in the bladder and pathologies commonly seen 
with increasing age (10). In a recent study, a higher incidence was evident in females <40 years with an 
odds ratio of 6,125 when compared to women between 40-60 years (13). This can possibly be attributed 
to increased sympathetic tone as suggested by Tammela (10).  
 
2.7.2 Gender 
 
Gender difference related to the incidence of POUR is controversial. Some studies showed the incidence 
of POUR to be higher in men (10, 12, 45, 46, 51), while others showed no significant difference between 
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men and women (4, 11, 14). In a study where patients received spinal anaesthesia with 2% prilocaine, 
female gender was identified as a predisposing factor for POUR with an odds ratio of 4.36 (95% 
confidence interval 1,48-12,87) in comparison to men. In this study the mean age of the participants was 
46 years (13), therefore increased sympathetic tone in the younger women may have contributed to this 
finding (10). BPH and other gender specific pathology  may be implicated in the studies with a significant 
difference (8).  
 
2.7.3  Type of surgery 
 
An association between the incidence of POUR and major surgery (14), perineal surgery (1, 50), inguinal 
hernia repair (18), emergency surgery (10, 11), thoracotomies , hip and knee arthroplasties (10, 52) and 
laparotomies (10) have been documented. POUR is the most common complication after anorectal 
surgery. The mechanism is unclear and may be multifactorial including decreased sensation, pain, 
increased sympathetic activity and outflow obstruction due to edema. (50) Lamonerie (4) did not find 
any correlation between type of surgery and the incidence of POUR in a study population who had 
various types of surgery including thoracic, vascular, abdominal, orthopaedic or ear nose and throat 
(ENT) surgery (4).  Gynaecological surgery was not associated with an increased risk for POUR. The 
bladder is often drained with in-out catheterisation during gynaecological surgery which may contribute 
to this finding. (1)   
 
2.7.4 Duration of surgery and anaesthesia 
 
A duration of surgery more than one to two hours has been associated with POUR (4, 14). An odds ratio 
of 3.03 (95% confidence interval 1.39-6.61) was documented for surgery > 2 hours (4). The association 
between the incidence of POUR and the duration of anaesthesia is controversial (11, 14, 37).  Hansen 
(11) documented an odds ratio of 1.88 (p 0.032) for anaesthesia of > 2 hours. Higher volumes of 
intravenous fluids and dosages of opioids in longer surgery may play a role (4).  
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2.7.5 Anaesthetic technique and duration of anaesthesia 
 
Urinary retention is a well known complication of spinal and epidural anaesthesia secondary to changes 
in sensation and a blocked micturition reflex  (4, 11, 18-20, 50). A delay in voiding after spinal or epidural 
anaesthesia of 213 minutes has been documented (18). An odds ratio of >3 was documented in more 
than one study for POUR in patients who had spinal anaesthesia (4, 11). In a study comparing spinal 
anaesthesia and paravertebral block, the incidence of POUR in the group that received paravertebral 
block was 0% while the group that had spinal anaesthesia had an incidence of 16% (19). 
 
2.7.6 Intravenous fluids 
 
In several studies the amount of fluid administration did not increase the incidence of urinary retention 
in patients at low risk for POUR (1, 13). Other studies showed a correlation between  high amounts of 
intravenous fluid and POUR (14, 37) especially after spinal anaesthesia (24). Multiple factors may 
influence the result such as pre-operative fluid balance, renal function and volume of blood loss. (13) 
Tammela (10) identified intravenous fluid as a predisposing factor for POUR. This study included all 
patients who were diagnosed with POUR over a period of one year. The study sample included patients 
with various possible risk factors including neurologic disease, elderly, history of abnormal voiding and 
patients who received medications with effects on the lower urinary tract. Bleeding in 79.3% of patients 
was less than 500 ml and patients received a total amount of intraoperative fluids of 4000 ml or less. 
(10) The contribution of intraoperative fluid to POUR reported by Tammela (10) may be due to excessive 
fluid administration. Pavlin (1) suggested excessive fluid administration in an attempt to overcome the 
delay of voiding after surgery increases the risk of POUR where bladder function may be abnormal . 
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2.7.7 Medications 
 
The medications with possible effects on the lower urinary tract have been discussed above. A 
discussion of results of several studies will follow. 
Opioids 
Kumar (53) documented the mean morphine requirements post-operatively to be a predictive factor of 
POUR (p=0.035). 
A study showed the incidence of urinary retention associated with patient controlled analgesia (PCA) 
was 38.7% which was comparable to epidural analgesia where the incidence was 49.4%. In both these 
groups the incidence of retention decreased significantly (p<0.05) to 4.84% and 5.6% respectively after 
the PCA and the epidural was stopped. (8)  
Intrathecally administered opioids may cause a dose-dependent decrease in detrusor contractility and a 
decreased sensation to void. The duration of the effects may be dependent on the pharmacokinetics 
and the dose of the opioid used. Kuipers et al. (25) did urodynamic evaluations before and every hour 
after administration of intrathecal morphine and sufentanil to evaluate the effects on the lower urinary 
tract. Recovery after intrathecal sufentanil was faster than morphine and the duration of the effects 
were thought to be dependent on the pharmacokinetics and the dose of the opioid used. (25) This is in 
contrast to Stoelting (40) who stated urinary retention related to opioid use is not dose-dependent or 
related to systemic absorption. Patients may have a high residual volume after spontaneous voiding due 
to abnormal bladder function caused by the opioids. (25)  
The adverse effects of opioids, including POUR, can be reversed by naloxone and methylnaltrexone. 
Methylnaltrexone has the added advantage of not reversing the analgesic effect of opioids. (44) 
Local anaesthetic agents 
The physicochemical properties of local anaesthetics play a role in the incidence of POUR. Longer acting 
local anaesthetics have been associated with an increased incidence of POUR when administered 
intrathecally (24, 37, 50). 
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Other 
Anticholinergics , sympathimimetics, β-blockers, α-sympatholytics, clonidine/methyldopa and calcium 
channel blockers were mentioned in an article by Tammela as possible contributing agents to post-
operative urinary retention (10). The anticholinergic, atropine, was identified as an independent risk 
factor of POUR by Dreijer (43). In other studies anticholinergic and opioid dosages were also associated 
with increased post-void residual volume (1). In contrast, Kreutziger (13) found no correlation between 
POUR and ephedrine, analgesia, atropine and midazolam in a pilot study with a study sample of 86 
patients. Literature on the effects of these medications on the lower urinary system is limited. 
 
2.7.8 Comorbidities 
 
Patients with previous stroke, cerebral palsy, multiple sclerosis, alcohol or diabetic neuropathy and 
spine fractures may have abnormal voiding and should be documented preoperatively (10). Diabetes 
mellitis is a common comorbidity and has been associated with POUR in several studies (43, 46, 51). The 
prevalence of bladder dysfunction is 43 – 87% and 25% in type 1 and type 2 diabetes mellitus 
respectively. Bladder dysfunction is due to a decrease in bladder sensation which lead to increased 
bladder capacity and overdistention of the bladder, decreased bladder contractility and increased 
residual volume. This abnormal functioning of the bladder may be asymptomatic despite the 
abnormality demonstrated on investigations. (49)  Other comorbidities shown to be predictive of POUR 
include renal failure and psychiatric illnesses e. g. depression and psychosis not otherwise specified (46).  
Antidepressant and antipsychotic agents may play a role in the development of POUR as discussed 
earlier. (42, 46) 
 
2.7.9 Previous history of abnormal voiding 
 
Patients with BPH (8, 10), prostate cancer, previous damage to the lower urinary tract or a history of 
POUR are at increased risk for POUR (10). Undiagnosed BPH may contribute to POUR (8). The use of a 
urinary tract symptom questionnaire to predict POUR may be useful (12, 16, 17, 52). The International 
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Prostate Symptom Severity Score (IPSS), a validated score developed by the American Urological 
Association used to quantify the severity of outflow obstruction in men (12, 17), was used in a study to 
determine predictability of POUR based on the score (12, 17). The overall scores obtained from the IPSS 
and comparable questionnaires in patients who had POUR were higher than the patients who could void 
spontaneously. A study by Cronin (17) suggested IPSS to be a reliable tool to predict POUR while the 
score was found not to be statistically significant in the study by Sarasin. (12, 17)  
 
2.7.10 Bladder volume 
 
A correlation has been documented by several studies between urinary retention and patients who did 
not void prior to transport to theatre or who have bladder volumes of more than 100-270 ml before 
induction of anaesthesia (11, 14, 20). Patients who void before transport to theatre may still have 
significant bladder volumes at the time of induction of anaesthesia. In a study where patients voided 
before being transported to theatre three patients had bladder distention before induction of 
anaesthesia. Two of these patients had bladder volumes prior to induction of >500ml. (54) 
An association between bladder volume at the end of surgery or on admission to the post anaesthesia 
care unit (PACU) have also been documented in several studies (1, 6, 14, 47). A bladder volume of more 
than 300 ml at the end of knee arthroplasty has a 6.5 times higher risk of POUR (20). A study by Feliciano 
(6)  identified a strong association between the bladder volume on admission to the PACU and POUR. In 
this study 50% of patients admitted to the PACU had bladder volumes of more than 500 ml and 90% of 
these patients were unable to void and required catheterisation. (6) This correlates with the study by 
Voelckel (47) who identified a bladder volume of more than 300 ml immediately post-operative as a 
strong indicator of POUR (47).  
 
2.7.11 Mobilisation 
 
The inability to mobilise post-operatively predisposes patients to POUR (10, 13). In a study 20.2% of 
patients with POUR were not able to sit or stand post-operatively and most of these patients only 
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voided spontaneously once they were able to stand (10). The association between immobilisation and 
POUR have been documented in several studies (10, 13, 41) 
 
2.8 Diagnosis  
 
The diagnosis of POUR is most commonly made by three possible methods: clinical examination, 
catheterisation and ultrasound. 
 
2.8.1 Clinical recognition of urinary retention  
 
Urinary retention can easily be missed when relying on clinical assessment alone. Clinical recognition of 
bladder distension includes the patient complaining of discomfort or pain in the lower abdomen 
associated with an inability to void, hypertension in the absence of pain or chronic hypertension, and a 
palpable bladder above the pubic symphysis. (6, 9) 
Patients might be unaware of bladder distension in the post-operative period due to an obtunded state 
(53), decreased sensation related to opioid administration (25) or neuraxial anaesthesia resulting in 
decreased sensation and a blocked micturition reflex (4, 11, 18-20, 50).  Patients may therefore be 
unable to alert nursing staff (53) in the post-operative period. In a study by Pavlin (1), patients with a 
bladder volume of > 500 ml, only 50% recognised a feeling of bladder fullness (1). This was similar to a 
study by Lamonerie (4), where 44% of patients had a bladder volume of >500 ml on ultrasound when 
they were otherwise ready for discharge from the PACU. Only 46% of the patients with a bladder 
volumes >500 ml experienced a feeling of a full bladder. (4) 
Palpation and percussion of the lower abdomen may cause significant discomfort and pain to the 
patient with a full bladder, especially to the patient with an abdominal wound. Guarding and obesity are 
two factors which limit palpation of the bladder. The fat distribution in the elderly are more on the 
abdomen which may contribute to late recognition of bladder distension (9). In elderly patients the 
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adverse effects of bladder distension may be more detrimental since there is already decreased blood 
flow, degeneration of bladder innervation and decreased muscle activity. (2, 53)  
The recognition of urinary retention based on clinical assessment is unreliable (23). The diagnosis of 
POUR by nurses, based on the history of the amount of fluid administered and patient examination, 
corresponded with only 54% of diagnosis made by ultrasound. In this study urinary retention was 
defined as a volume of > 600 ml on ultrasound measurement associated with an inability to void. (1) 
Warner et al (9) recognised  a significant difference in the incidence of urinary retention when the 
diagnosis was made with ultrasound (bladder volume >400ml considered to prompt further action), 
compared to the detection based on clinical examination. The incidence was 19.4% and 1.4% 
respectively. This indicated the need for an improved bladder protocol in their PACU. The protocol used 
at that time guided the need for bladder palpation, and took into consideration blood loss, intravenous 
fluids, time patient has not voided (6 hours or more), theatre time of more than 4 hours, and elevated 
blood pressure without a history of hypertension and no pain. (9)  
 
2.8.2 Catheterisation 
 
Catheterisation has been used for several years to diagnose urinary retention. It has the added benefit 
of simultaneous relieve of urinary retention but it is not without risk. Compared to ultrasound, 
catheterisation is invasive. Patients are predisposed to possible infection, trauma, urethral stricture and 
a prolonged hospital stay (17). The associated embarrassment and discomfort may decrease patient 
satisfaction (6). It is also a time-consuming task for staff and has cost implications (5, 6, 20, 23). 
 
2.8.3 Ultrasound 
 
Ultrasound is a more effective means of making the diagnosis of urinary retention than manual 
palpation (9, 23) with almost no discomfort to the patient (9, 20, 55). The routine use of ultrasound in 
the post-operative period to aid early diagnosis of urinary retention, especially in high risk patients, has 
34 
 
been suggested in various studies (1, 4, 11, 13, 23). Some centres use ultrasound routinely in their PACU 
(6, 13). 
The literature available pertaining to post-operative urinary retention and ultrasound measurement of 
bladder volume used a wide range of volumes at which intervention was considered. The bladder 
volumes in these studies ranged from 300 ml – 600 ml. (1, 5, 8, 11)  
Ultrasound is a non-invasive, cost-effective and accurate assessment tool. The reliability and accuracy of 
ultrasound has been demonstrated in previous studies (5, 9, 13, 18, 23, 55). The mean difference in 
urine volume estimated by ultrasound compared to the immediate volume drained with a catheter was 
21.5 ml and 54 ml in two separate studies (18, 23). Rosseland (23) conducted a study to establish the 
reliability of ultrasound. The mean volume of urine measured by ultrasound was 21.5 ml less than that 
drained with immediate catheterisation (95% confidence interval -147ml and +104 ml). (23)  In the other 
study the correlation coefficient was 0.89 over a range of volumes of 180-1100 ml indicating the volume 
drained with catheterisation correlated well with the volume measured by ultrasound (18).  
 Lee et al (5) demonstrated the benefit of an ultrasound programme guiding the decision for 
catheterisation. Unnecessary catheterisation in this study was considered to be a urine volume of <300 
ml drained immediately after catheter insertion in a patient who did not void for a period of time (time 
not specified) or <100 ml residual volume after spontaneous voiding. Without ultrasound the rates of 
unnecessary catheterisations were 35.3%. There was a significant reduction in urinary tract infection 
rates of 59.94% six months after the implementation of the ultrasound programme in their 
neurosurgical ward (5).  
Monitoring of bladder volume with ultrasound during the post-operative period has been advocated, 
especially in patients who have had spinal anaesthesia, anaesthesia and surgery time more than two 
hours, anorectal surgery, hernia repair, emergency surgery and the elderly. (1, 4, 11, 18, 20, 23) Limiting 
factors to ultrasound are the initial cost to purchase, training of staff and the questionable accuracy of 
ultrasound when the pelvic anatomy is abnormal. (9) Portable ultrasound devices (e. g. BladderScan BVI 
2000™, BladderScan BVI 2500™, BladderScan BVI 3000™) were introduced and have proven to be easy 
to use (55) with minimal training required. It allows an assessment of bladder volume by the press of a 
button and does not require interpretation of an ultrasound image. The volume of the bladder is 
displayed on a LCD screen. (56) Further studies are needed to assess the accuracy of these devices when 
bladder anatomy is abnormal (55). 
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In the longterm, the implementation of a bladder programme monitoring patients’ bladder volumes 
post-operatively may be more cost-effective (9). The use of ultrasound may reduce unnecessary 
catheterisations (5, 55), the rates of urinary tract infections (5) and other adverse effects from bladder 
overdistention. The cost implicated for treatment of a urinary tract infection secondary to 
catheterisation includes medication and a prolonged hospital stay (5).  
 
2.9 Adverse effects of bladder overdistension 
 
Bladder overdistension may decrease patient satisfaction, cause abnormal voiding, recurrent or 
persistent urinary tract infections and reflux. It also increases cost of patient care when treatment of the 
associated adverse effects is considered (6, 46). 
Bladder overdistension may cause significant discomfort and pain to the patient. The patient may 
present with hypertension or hypotension, dysrhythmias, vomiting, restlessness and confusion. (4, 6, 23) 
This impacts negatively on patient satisfaction (6). 
Prolonged stretching of the bladder is thought to result in loss of elastic and contractile ability of the 
bladder, a decrease of cholinergic receptors in the bladder wall and irreversible damage to the motor 
nerves and postjunctional membrane (1, 2). It may also result in ischemia, vesicourethral reflux and 
bacteria entering into venous and lymphatic systems. Consequently, patients may require prolonged 
hospital stay. (5, 53) 
During bladder distension the blood vessels may be stretched to such a degree, that the blood flow to 
the bladder is decreased.  Intramural tension is the principle determinant of blood flow to the bladder. 
Intravesical pressure increases significantly with overdistension of the bladder, leading to increased wall 
tension. Ischaemic injury may cause decreased bladder compliance, decreased ability of the bladder to 
contract, patchy denervation of the bladder wall and a change in the micturition threshold. (3) Motility 
disorders of the bladder are often seen after prolonged overdistension of the bladder (3-5) which may 
be the result of structural and functional abnormalities (18). Transient bladder distension with volumes 
of between 500-1000 ml may not be harmful if detected and managed within one to two hours (18). The 
adverse effects of bladder overdistension may be more pronounced in the elderly due to age-related 
decreased blood flow to the bladder wall and degeneration of the innervation of the bladder (2, 53).  
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In 1985, Tammela (2) investigated possible predisposing factors to prolonged abnormal voiding after 
bladder distension. At that time, there was no literature available that investigated possible contributing 
factors. The factors that were identified in this study included the amount of intravenous fluid, urine 
volume at first urinary retention and increasing age. Limitations of this study were that of the total 
patients catheterised, only 8% were catheterised within six hours from the end of surgery, 50.5% of 
patients were only catheterised more than 12 hours post-operatively and included patients who had 
overflow incontinence. The first urine volume drained in 37% of the patients was more than 1000 ml. (2) 
The patients in this study probably had prolonged bladder overdistension which will explain the high 
incidence of prolonged abnormal voiding of 61%. In contrast, patients who had bladder volumes of more 
than 900 ml in a study by Pavlin (18), none had abnormal voiding. This may be due to earlier recognition 
and drainage (18). 
Patients who had bladder overdistension should be questioned post-operatively about new urinary tract 
symptoms including frequency, nocturia, hesitancy, urgency, weak stream, dysuria, incontinence, 
enuresis and an inability to empty bladder to identify patients with adverse effects secondary to high 
bladder volumes. (1) 
Even when patients void spontaneously in the post-operative period, they may have a significantly high 
residual urine volume which may be close to the normal bladder capacity (1, 20). The residual volume is 
higher in patient considered to be at high risk of POUR including patients who had anorectal surgery, 
inguinal hernia repair or a history of urinary retention. The patient with a high residual volume is at 
increased risk for bladder overdistension . (1)  
Bladder distension and residual urine volume predispose patients to acute recurrent and chronic urinary 
tract infections, reflux and overflow incontinence (5, 53). Normally the oblique passage of the ureters 
through the layers of smooth muscle of the bladder provides sufficient closure of the ureters to prevent 
reflux of urine. There are no sphincters in the ureters. (3) Bladder overdistension may change the 
adequacy of this mechanism resulting in reflux of urine.  
Prolonged stay in PACU or in the ward has implications for resources and costs (6). Urinary retention is 
one of the most frequent contributors to delayed discharge from the PACU (7). 80% of patients with a 
retention urine volume of >750 ml required a prolonged hospital stay of 8.6±5.1 days in males and 
6.25±2.6days in females (2). 
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Patients required to void prior to discharge may prolong recovery time even in patients who do not have 
POUR (6, 7). The ability to void as a prerequisite for discharge is being reconsidered. It may cause 
unnecessary prolonged discharge time in patients at low risk of urinary retention. Mulroy (37) suggested 
that patients at low risk for urinary retention who had spinal or epidural anaesthesia with short acting 
agents may be discharged prior to voiding, provided they are reliable and have access to a medical 
facility. When this is considered, patients should be educated on when to seek medical help. The 
discharge time was significantly shorter. The safety of this practice still needs to be investigated. (37)   
 
2.10 Management options for POUR 
 
2.10.1 Prevention  
 
Identifying the patient at risk for POUR prior to surgery and implementation of a monitoring protocol 
may decrease the incidence of POUR. It may be beneficial to limit contributing factors where possible in 
all patients presenting for surgery. (5, 6, 20, 23, 42, 53) Various contributing factors may increase the 
risk of POUR. A high index of suspicion should be maintained especially in patients with a history of 
symptoms of the lower urinary tract. (53) 
An adequate voiding history should be obtained from all patients booked for surgery. Patients who have 
abnormal voiding should consult an urologist for appropriate intervention before elective surgery. All 
patients booked for emergency surgery with abnormal voiding should be catheterised preoperatively. 
(10)  
When choosing an anaesthetic technique, the possibility of POUR as a complication should be 
considered especially in patients who have other risk factors. 
Paravertebral block is an alternative to spinal anaesthesia for inguinal hernia repair. The side-effects 
associated with paravertebral block are significantly less than spinal anaesthesia, including urinary 
retention. It is an easy block to learn and it provides adequate post-operative analgesia which lasts on 
average 1-3 hours longer than spinal anaesthesia. The bilateral motor block associated with spinal 
anaesthesia limits mobilisation of patients post-operatively. Conversely, patients who received a 
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paravertebral block are able to mobilise early. Further studies need to be conducted to compare 
unilateral spinal with paravertebral block. (19) 
Although the literature is limited regarding the association between medications and POUR, the choice 
of medications used should also be taken into account. A multimodal approach to post-operative pain 
may decrease the incidence of POUR. NSAID use should be promoted while opioids should be limited to 
the lowest effective dose. (15, 42). 
Short acting local anaesthetics for spinal or epidural anaesthesia have a lower risk of POUR. Urodynamic 
assessment was used in healthy young adult men to evaluate the effects of intrathecal opioids on 
bladder function. Recovery of normal detrusor function after intrathecal sufentanil was faster compared 
to morphine which can be explained by the pharmacokinetics. Duration and intensity of suppression of 
detrusor muscle function and sensation to urge was dose-dependent. (25) It may be beneficial to use 
shorter acting opioids and local anaesthetic agents intrathecally (24, 25). 
Although the contribution of peri-operative fluid to urinary retention is controversial, the administration 
should be individualised and guided by blood loss and hemodynamic status. Excessive intravenous fluid 
is associated with higher residual bladder volumes post-operatively which may predispose patients to 
bladder distension (1).  Hansen (11) suggested patients should void before they are transported to 
theatre. There was a strong association between lack of preoperative void and a post-operative bladder 
volume of > 400 ml which predisposed patients to urinary retention. (11) 
Ultrasound monitoring in the post-operative period may facilitate early detection of POUR. (20, 23, 47) 
Patients are often unaware of a residual bladder volume after spontaneous voiding in the post-operative 
period. Studies showed that 61% of patients with a bladder volume of >600 ml did not experience 
urgency to void or discomfort post-operatively. (1) Patients should be monitored with ultrasound even 
after spontaneous voiding to detect a significant residual volume (1, 20). A significant residual volume 
should prompt health care providers to monitor the patient closely in the post-operative period. Luger 
(20) suggested the bladder should be drained with in-out catheterisation in theatre if the patient’s 
bladder volume is > 300 ml at the end of surgery. If the volume is < 300 ml they should be monitored 
with hourly ultrasound measurements of bladder volume. (20) 
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2.10.2 Non-invasive interventions 
 
When urinary retention is suspected or diagnosed, non-invasive measures can be instituted to promote 
micturition. These measures include:  
1. Encourage the patient to attempt to void  
2. Provide a quiet, relaxed environment 
3. Audible running water in the patient’s room 
4. Place the patient’s hand in warm water, or allow the patient to take a hot bath 
 5. Encourage early sitting, standing or ambulation 
6. Minimize post-operative discomfort   
7. Instruct on specific time interval in which the patient should void before non-conservative 
management is considered. (10, 21, 41) In a study by Stallard (41) > 50% of patients with POUR voided 
after implementation of non-invasive measures. 
Kamphuis (24) suggested encouraging patients to void with abdominal strain when their bladders are 
full and if the patients are still unable to void after conservative measures, a single in-out catheterisation 
may be considered (24).   
Whether threshold values have been documented for bladder volumes at different periods of time post-
operatively to indicate if spontaneous voiding after spinal will be possible or not, is not known. (20). The 
mean time to void after spinal anaesthesia in patients for arthroscopic knee surgery was 238±15 min 
(20) compared to a mean time to void in patients who had non-pelvic surgery of 75 minutes (1). 
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2.10.3 Pharmacological management 
 
Pain can cause significant sympathetic activity and contribute to POUR (9). When considering 
medication for the treatment for POUR, the first consideration should be adequate pain relief. Analgesia 
should be multimodal and opioid use should be limited if possible (15, 41, 42, 46). 
Selius (15) mentions that prazocin, an α-receptor anatagonist,  has been documented in the literature to 
decrease post-operative urinary retention in men. The mechanism by which the α-adrenergic 
anatagonists are thought to promote micturition, is by relieving the increased sympathetic activity 
associated with bladder overdistension (2, 10, 42, 48).  
β-adrenergic agonists may also be beneficial and dopaminergic agonists may produce near complete 
emptying of the bladder (48), but literature on these medications and the effects on bladder function 
are limited. 
Carbachol, a cholinergic drug, have been used to promote micturition before catheterisation (10, 48) 
although a study have shown it to be ineffective in prevention of prolonged micturition problems (2). 
Tammela (2) considered the ineffectiveness to be either due to decreased blood flow to the bladder and 
nerve denervation as a result of bladder overdistension or the doses given were too low (2). 
 
2.10.4 Role of catheterisation 
 
In the 1980’s, catheterisation was considered to be more of a concern than bladder overdistension. 
Patients were encouraged to void and fluid was restricted. A study conducted by Tammela (2) to 
investigate post-operative micturition problems  suggested that catheters should not be inserted 
routinely, but the decision should be individualised, and patients who had a retention volume of > 500 
ml, should remain catheterised for a few days in order for the bladder to regain normal function, or 
patients should be catheterised again as needed to prevent re-retention. (2) 
There is consensus that catheters should only be inserted when indicated and for the shortest duration 
possible (53, 57). The question as to whether in-out catheterisation or indwelling catheterisation is more 
41 
 
beneficial has not been resolved. A bladder volume of > 500 ml on admission to PACU was strongly 
associated with POUR in univariate analysis in a study by Feliciano (6). In-out catheterisation in high risk 
patients at the end of surgery or on admission to the PACU has been suggested (6, 15).  
In a prospective randomized trial where urinary retention was defined as the need for catheterisation in 
the presence of a palpable bladder and inability to void or a bladder volume on ultrasound of >500 ml, 
there was no significant difference between in-out catheterisation when needed and indwelling 
catheterisation for 24 hours with regard to re-retention, infection rates and length of hospitalisation. 
Patients received only a single dose of parenteral antibiotics at induction of anaesthesia. They 
recommended in-out catheterisation because indwelling catheter had no additional benefit. (50) 
Catheterisation in the post-operative period may be more challenging due to wound dressings, post-
operative pain, sedation and lack of mobility of the patient. These difficulties may compromise the ideal 
aseptic technique used during catheterisation (8). 
 Urinary tract infections are the most common nosocomial infections, in which 80% are associated with 
urinary catheters (5, 57). Studies have shown that urinary tract infection rates decrease when 
unnecessary catheterisations are avoided (5, 18).  
The risk of acquiring a urinary tract infection is estimated to be 3-7% for each day a patient has an 
indwelling catheter in situ. The most important risk factor being the duration of catheterisation. (57) 
Kumar (53) stated, with reference to previous studies done, there is no significant increased risk of 
urinary tract infection with indwelling catheter for 48 hours or less compared to in-out catheterisation 
(53). Catheterisation should be limited to absolute indications after other methods of management have 
been considered, and the catheter should be removed as soon as possible. Routine use of antibiotics as 
prophylaxis is not recommended. (57) 
Catheterisation and urinary tract infections may be associated with deep wound sepsis in patients who 
had hip and knee arthroplasty, possibly through haematogenous spread (8, 53, 58). In order to minimise 
the risk of deep wound sepsis, the following suggestions regarding catheterisation were made:  strict 
aseptic technique, avoid multiple catheter insertions, keep the duration of catheterisation as short as 
possible and antibiotic cover when a catheter is inserted in a patient at increased risk for deep wound 
sepsis e.g. elderly, obese, higher ASA scores (58).  
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Bladder ultrasound may be cost-effective in that there is decreased risk of trauma, decreased iatrogenic 
infection and decrease nursing time. (9, 18, 23) 
 
2.11 Summary  
 
This chapter contained a literature review on POUR. It included patient satisfaction and safety, the 
definition of POUR, an overview of the applicable anatomy, physiology and pharmacophysiology, the 
occurrence of POUR, the pathophysiology involved in urinary retention, risk factors associated with 
POUR, the diagnosis of POUR and management options for POUR. 
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CHAPTER THREE 
RESEARCH METHODOLOGY 
 
3.1 Introduction 
 
In this chapter the problem statement, aims and objectives, ethical considerations, research 
methodology and validity and reliability will be discussed in detail. 
 
3.2 Problem statement 
 
Urinary retention is a common underdiagnosed post-operative complication that results in patient 
discomfort and possible permanent damage to the lower urinary tract. Reliable early detection of POUR 
is possible with an ultrasound of the bladder. This method of detecting a full bladder is not readily 
available for post-operative patients at CHBAH.  
 
There was a perception that a number of post-operative adult patients at Chris Hani Baragwanath 
Academic Hospital (CHBAH) considered to be at low risk of POUR did develop urinary retention. Patients 
known to be at high risk of POUR are usually monitored closely and POUR can be diagnosed timeously. 
Voiding may not be considered to be as important as other monitored parameters in the patient at low 
risk of POUR and may predispose patients to late diagnosis in the post-operative wards. The occurrence 
of POUR at CHBAH was unknown.  
 
3.3 Aim 
 
The aim of this study was to describe the occurrence of POUR in adult patients at low risk of POUR who 
presented for elective surgical procedures at CHBAH and to determine if this was influenced by age, 
gender or type of anaesthetic received.   
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3.4 Objectives 
 
The primary objective of this study was to describe the occurrence of POUR in low risk patients following 
elective surgical procedures. 
The secondary objectives of this study were to: 
• determine if the occurrence of POUR was influenced by: 
• the type of anaesthetic  
• the age of the patient  
• the gender of the patient 
• describe the medications administered in the peri-operative period. 
 
3.5 Ethical considerations 
 
Approval to conduct this study was received from the Post Graduate Committee (Appendix D) and the 
Human Research Ethics Committee (Medical) (Appendix E) of the University of the Witwatersrand and 
the Chief Executive Officer (Appendix F) of CHBAH.  
 
The proposed project was discussed with the various heads of the surgery departments and the nursing 
managers of the different post-operative wards and verbal consent was obtained from these parties. 
 
Participants were invited to take part in the study. The study was explained to all potential participants 
identified by the researcher. An information letter (Appendix A) was given to those who agreed to 
participate, and written informed consent was obtained. A translator was available to assist participants 
who did not understand English, however translation was not necessary. No identifying information was 
recorded on the data collection sheets and the lists of participants’ names were kept in a separate file 
thereby ensuring anonymity. Confidentiality was maintained as only the researcher and the supervisors 
had access to the raw data. Data will be securely stored for six years following the completion of this 
study.  
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If the researcher identified a participant with POUR the nursing staff and the treating doctor would have 
been notified. 
The study was conducted according to the principles of the Declaration of Helsinki (28) and the South 
African Good Clinical Practice Guidelines (29).   
 
3.6 Research methodology 
 
3.6.1 Research design 
 
A prospective, contextual, descriptive study design was used. 
 
In prospective studies, data about a presumed cause are first collected before the effect or outcome is 
measured. The variables being measured occurred during the study (59), as in this study.  
 
A contextual study is conducted within a specific location where a problem is identified (59). This study 
was done at CHBAH. 
 
A descriptive study is a study in which phenomena are described or the relationship between variables 
are examined and no attempt is made to determine cause-and-effect relationships, nor is any 
intervention made (59, 60). It is merely to obtain more information within a particular field (60). This 
study was descriptive as it described the occurrence of POUR in patients who presented for surgery at 
CHBAH and were at low risk for POUR.  
 
3.6.2 Study population 
 
The population for this study was adult patients in the post-operative wards who were at low risk for 
POUR and received either general anaesthesia or a neuraxial block during their elective surgical 
procedure. 
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3.6.3 Study sample 
 
Sample size 
In consultation with a biostatistician a sample size of 150 participants was calculated using the program 
nQuery Advisor. When the sample size is 150, a two-sided 95.0% confidence interval for a single 
proportion using the large sample normal approximation will extend 0.069 from the observed 
proportion for an expected proportion of 0.250. (61) 
 
From a sample size of 150 patients it could be expected that 25% would have POUR to an accuracy of 7% 
with 95% confidence. 
 
Sampling method 
A convenience sampling method is a non-probability sampling procedure. It involves the selection of the 
most readily available patient for the study. (59) In this study readily available participants were invited 
to participate in the study during office hours until the sample size was realised.  
 
Inclusion and exclusion criteria 
The following inclusion and exclusion criteria were used. 
Inclusion criteria: 
• elective surgical patients who were at low risk for POUR in the following surgical disciplines: 
orthopaedics, general surgery ,ENT, maxillo-facial, plastics and ophthalmology 
• inpatients who were admitted to CHBAH for a minimum of 24 hours post-operatively 
• patients 18 years and older 
• patients who gave consent to take part in the study. 
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Exclusion criteria: 
• Patients with a previous history of POUR or any urinary tract related problems including: 
o nocturia 
o frequency 
o urgency 
o hesitancy  
o incontinence 
o weak stream 
o dysuria  
o known BPH or other prostate pathology 
o urinary tract infection within the last week 
• known diagnosis of renal dysfunction 
• indwelling urinary catheter in situ 
• catheterisation (in-out or indwelling) during the surgical procedure  
• no intravenous fluid administered peri-operatively  
• hyperglycemia 
• diuretic use 
• surgery considered to be high risk for POUR including: pelvic surgery, anorectal surgery, inguinal 
hernia repair, spine surgery, neurosurgery  
• known neurologic pathology 
• continuous epidural anaesthesia or analgesia 
 
3.6.4 Data collection 
 
Potential participants from the specified surgical disciplines were identified from the theatre booking 
lists in the CHBAH J.D. Allen Theatre Complex the day before surgery or on the day of surgery but before 
the patient arrived in theatre from the ward. 
 
The participants were approached in their respective wards before surgery. An information letter 
(Appendix A) was given to each participant and the researcher explained the purpose of the study and 
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what the participant may expect. The participants were given an opportunity to ask the researcher 
questions about the study. If the participant agreed to participate in the study, written informed 
consent (Appendix B) was obtained. 
 
The researcher approached the participants 12 – 24 hours following surgery and collected the following 
information from the participants, the anaesthetic record and the participants’ files using the data 
capture sheet (Appendix C). The following data was collected:  
• age 
• gender 
• type of surgery 
• length of procedure 
• type of anaesthetic  
• ability to void spontaneously or catheterised since admission to the ward following surgery 
• non-invasive interventions done by the nursing staff if the patient was not able to void 
spontaneously 
• if the patient was catheterised, document the volume and whether in-out or indwelling 
catheterisation was done 
• amount of peri-operative fluids administered 
• medications received peri-operatively. 
 
If the participant had not voided spontaneously and no successful intervention had been done at the 
time the researcher approached the participant post-operatively, the researcher would inform the 
nursing staff of the respective ward and the treating doctor. 
 
3.6.5 Data analysis 
 
Data was captured onto a Microsoft Excel spread sheet and analysed using the statistical program 
STATISTICA 10.0. Frequencies and percentages were used to describe the variables in the study.  
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3.7 Validity and reliability of study 
 
“Validity indicates whether the conclusions of the study are justified based on the design and 
interpretation” and “reliability represents the consistency of the measure achieved” (62).  
 
Validity and reliability of this study was ensured by: 
• using an appropriate study design 
• determining the sample size in consultation with a biostatistician 
• having stringent inclusion and exclusion criteria 
• the researcher being the only data collector 
• using a standardised participant data collection sheet 
• selecting participants from a number of different disciplines to ensure a representative sample. 
    
3.8 Summary 
 
In this chapter the problem statement, aim, objectives, ethical considerations, research methodology 
and the validity and reliability of this study were presented. In the following chapter the results are 
presented and discussed.  
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CHAPTER FOUR 
RESULTS AND DISCUSSION 
 
4.1 Introduction 
 
In this chapter the results and a discussion of the results are presented. The results are presented 
according to the research objectives. The results are rounded off to two decimal places and therefore 
totals might not add to 100%. 
The primary objective of this study was to describe the occurrence of POUR in low risk patients following 
elective surgical procedures. 
The secondary objectives of this study were to: 
• determine if the occurrence of POUR was influenced by: 
• the type of anaesthetic  
• the age of the patient  
• the gender of the patient 
• describe the medications administered in the peri-operative period. 
 
4.2 Results  
 
4.2.1 Sample realisation 
 
Data was collected from December 2013 to February 2014. During this three month period, 362 patients 
were identified from the theatre booking lists as potential participants. From these potential 
participants, 156 patients were included. The reasons for exclusion of the 206 patients are shown in 
Table 4.1. 
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Table 4.1 Exclusion criteria met by potential participants2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exclusion criteria No. of 
patients 
Percentage 
% 
Diuretic use 45 21.8% 
Patients not in the ward preoperatively 42 20.4% 
Surgery cancelled 35 17.0% 
Communication difficulty 22 10.7% 
Neurological fallout eg. Stroke, spinal pathology 14 6.8% 
Catheterisation pre- or intraoperatively 10 4.9% 
Patient refusal 6 2.9% 
Hyperglycemia  6 2.9% 
Surgery done with local anaesthesia only 5 2.4% 
Both diuretic use and hyperglycemia 4 1.9% 
Incontinence  2 1.0% 
Early discharge 2 1.0% 
Previous POUR  2 1.0% 
Urgency  2 1.0% 
Renal failure 2 1.0% 
Urinary tract infection 2 1.0% 
Weak stream 1 1.0% 
Hesitancy  1 1.0% 
Both hesitancy and dysuria 1 0.5% 
Both incontinence and dysuria 1 0.5% 
Incomplete data 1 0.5% 
TOTAL 206 101.2% 
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4.2.2 Demographic characteristics of the study sample 
 
The study sample included 59.6% (n=93) males and 40.4% (n=63) females, with a mean age of 36.7 years 
(SD 11.84077). The age range was between 18 and 69 years. 
The majority of participants had general anaesthesia 85.9% (n=134). The remainder had neuraxial 
anaesthesia 13.5% (n=21) and one participant, 0.6%, had both general and neuraxial anaesthesia.  
 
The surgical disciplines included maxillo-facial (30.1%, n=47), orthopaedic (28.9%, n=45), general surgery 
(18.0%, n=28), ENT (10.3%, n=16), ophthalmic (9.0%, n=14) and plastic (3.9%, n=6) surgery. The surgical 
disciplines are shown in Figure 4.1. 
 
Figure 4.1 Number of participants in each surgical discipline included in this study 2 
 
 
 
 
The length of surgery ranged between 20 to 250 minutes with the mean length of surgery of 99.27 
minutes (SD 51.12).  
 
The mean volume of intravenous fluid administered was 947.8 ml (SD 502.8). On 64.7% (n=101) of 
participants’ anaesthetic charts intravenous fluid volume was recorded as either a 1000 or 2000 ml, and   
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no intravenous fluid volume was documented on 9.0% (n=14) of participants’ anaesthetic charts.    
 
4.2.2 Primary objective: to describe the occurrence of POUR in low risk patients following 
elective surgical procedures. 
 
Only one participant (0.6%) from the study sample was not able to void spontaneously in the post-
operative period. The non-invasive techniques used by the nursing staff included encouraging this 
participant to void spontaneously, running tap water, easing discomfort and giving an intravenous fluid 
bolus. A retention volume of 2000 ml was recorded when an indwelling catheter was inserted.  
 
4.2.3 Secondary objective: to determine if the occurrence of POUR was influenced by the 
type of anaesthetic and describe the medications administered in the peri-operative period.  
 
The results of this study could not determine if the occurrence of POUR was influenced by the type of 
anaesthetic. The one participant (0.6%) who did have POUR had general surgery and received a general 
anaesthetic. She received opioids, propofol and atropine during the peri-operative period. The 
anaesthetic management of this participant who developed POUR was not significantly different from 
the other participants who also received a general anaesthetic.  
See Table 4.2, 4.3 and 4.4 for the use of medications in the peri-operative period in our study. 
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Table 4.2 The use of systemic opioids in the peri-operative period. 3 
 
 TOTAL GENERAL 
ANAESTHESIA 
NEURAXIAL 
ANAESTHESIA 
BOTH GENERAL 
& NEURAXIAL 
ANAESTHESIA 
NO. OF PARTICIPANTS PER  
ANAESTHETIC TECHNIQUE 
156 (100%) 134 (85.9%) 21 (13.5%) 1 (0.6%) 
SYSTEMIC OPIOIDS USE     
 NO. % NO. % NO. % NO. % 
INTRAOPERATIVE 
SYSTEMIC OPIOIDS 
66 42.3% 65 48.5% 1 4.8% 0 0% 
POST-OPERATIVE 
SYSTEMIC OPIOIDS 
19 12.1% 3 2.24% 15 71.4% 1 100% 
BOTH INTRA- & POST-
OPERATIVE OPIOIDS 
68 43.5% 65 48.5% 3 14.2% 0 0% 
NO SYSTEMIC OPIOIDS 3 1.9% 1 0.75% 2 9.5% 0 0% 
TOTAL % OF PARTICIPANTS 
RECEIVED OPIOIDS PERI-
OPERATIVELY 
153 98.0% 133 99.2% 19 90.4% 1 100% 
NEURAXIAL OPIOID USE  
NEURAXIAL OPIOID 16 10.2% Not applicable 15 71.4% 1 100% 
 
 
Two of the patients (9.5%) who had neuraxial anaesthesia (13.5%, n=21) did not receive any systemic 
opioids. In the group of patients who received neuraxial opioid and local anaesthetic (71.4%, n=15), one 
patient (6.7%) received systemic opioids both in theatre and in the post-operative ward and 80% (n=12) 
received systemic opioids in the post-operative ward only. Two patients (13.3%) received no systemic 
opioids in the peri-operative period. From the other group of patients who received only local 
anaesthetic neuraxially and no neuraxial opioid (28.6%, n=6), one patient (16.7%) received systemic 
opioids in the intra-operatively period only, three patients (50%) received systemic opioids in the 
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postoperative period only and two patients (33.3%) received systemic opioids in both the intra- and 
post-operative periods.   
 
Table 4.3 The peri-operative use of medications in the study at CHBAH 4 
 
Medication TOTAL GENERAL ANAESTHESIA NEURAXIAL 
ANAESTHESIA 
 TOTAL NO. OF 
PARTICIPANTS 
% NO. % NO. % 
PROPOFOL 132 84.6% 132 98.5% 0 0% 
OPIOIDS  153 98.1% 133 99.3% 20 95.2% 
BENZODIAZEPINE  22 14.1% 5 3.7% 17 81.0% 
KETAMINE 30 19.2% 29 21.6% 1 4.8% 
ATROPINE 59 37.8% 59 44.0% 0 0% 
β –AGONIST 14 9.0% 14 10.5% 0 0% 
α –AGONIST 17 10.9% 16 11.9% 1 4.8% 
β –BLOCKER 2 1.3% 2 1.5% 0 0% 
CALCIUM 
CHANNEL BLOCKER 
1 0.6% 1 0.8% 0 0% 
NSAID 138 88.5% 117 87.3% 21 100% 
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Table 4.4 The use of NSAIDS in the peri-operative period at CHBAH 5 
 
NSAID USE  GENERAL ANAESTHESIA NEURAXIAL ANAESTHESIA 
 NO. % NO. % 
TOTALS 117 87.3% 21 100% 
INTRAOPERATIVE 4 3.0% 1 4.8% 
POST-OPERATIVE 52 38.8% 17 81.0% 
BOTH INTRA-AND 
POST-OPERATIVE 
61 45.5% 2 9.5% 
NO NSAID USED 0 0% 1 4.8% 
 
 
4.2.5 Secondary objective: to determine if the occurrence of POUR was influenced by the age of the 
participant. 
 
The results of this study could not determine if the occurrence of POUR is influenced by age. The one 
participant who did have POUR was 35 years old. The mean age of the study sample was 36.7 years. 
 
4.2.4 Secondary objective: to determine if the occurrence of POUR was influenced by the 
gender of the participant. 
 
The results of this study could not determine if the occurrence of POUR is influenced by gender. The one 
participant who did have POUR was a female. The study sample consisted of 40.4% (n=63) females. 
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4.3 Discussion 
 
The prevention, early recognition and prompt management of post-operative complications improve 
patient satisfaction and quality of care (30). Patients presenting for surgery may not be counselled about 
all the possible complications related to the surgery or anaesthesia especially when the patient is 
considered to be at low risk for the specific complication. Patient satisfaction is higher in patients that 
are well informed (32). POUR can have a significant impact on patient satisfaction and the patient’s 
perception of quality of care (6, 30).   
 
POUR can result in significant discomfort,  delayed discharge from the PACU, increased cost of patient 
care, urinary tract infections (6) and acute or long term bladder function abnormalities (1-5). The 
development of urinary retention can be influenced by a variety of factors. There was a concern that a 
significant proportion of adult patients presenting for elective surgery at CHBAH developed POUR. The 
occurrence of POUR at CHBAH was not known. The aim of this study was to describe the occurrence of 
POUR in adult patients at low risk of POUR who presented for elective surgery at CHBAH and to 
determine if it was influenced by age, gender or the type of anaesthetic, and to describe the drugs used 
during the peri-operative period. 
 
Multiple factors are thought to contribute to the development of POUR including increasing age, type of 
surgery, duration of surgery and anaesthesia, anaesthetic technique, amount of intravenous fluids, 
medications, comorbidities, previous abnormal voiding and the inability to mobilise. Different types of 
bladder capacities are described. Anaesthetic bladder capacity is greater than functional or cystometric 
bladder capacity due to the effects of general or neuraxial anaesthesia (34).This larger capacity of the 
bladder during anaesthesia can result in bladder overdistention and increase the risk of POUR.  In any 
patient presenting for surgery there will be a variety of factors that are non-modifiable(e. g. age, gender, 
type of surgery) and factors that will be unavoidable (e.g. anaesthetic technique, immobility). A high 
index of suspicion should be maintained for POUR in any patient presenting for surgery.  In our study 
potential confounding factors were excluded in order to investigate the occurrence of POUR in a 
population at low risk and in whom the ability to void may not be monitored as closely in the post-
operative period compared to patients at high risk of POUR.  It is important to realise that POUR may 
not be recognised by patients due to sensory fallout after neuraxial anaesthesia or an obtunded state 
after a general anaesthetic (1, 4). 
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The occurrence of POUR in this study at CHBAH was found to be 0.6% (n=1). The occurrence of POUR in 
the literature ranges from <1% to >50% (1, 4, 7-10, 42, 45, 46). This wide variation can be attributed to 
the lack of a standard definition and a combination of various risk factors. The definitions used in the 
literature were based on a variety of factors alone or in combination. These factors included patient 
discomfort, time since operation, bladder volume on ultrasound post-operatively and the amount of 
urine drained at catheterisation (1, 6, 10, 11, 13, 14, 18, 19, 41). In our study the definition used for 
POUR was the inability to empty the bladder without non-invasive or invasive interventions in the post-
operative period. The diagnosis of POUR in our study depended on the nursing staff or recognition by 
the participant. Our study did not change usual practice at CHBAH in terms of diagnosing POUR. Many 
potential risk factors for POUR are recognised and some are controversial. The risk factors include type 
of surgery, medications, anaesthetic technique, duration of surgery or anaesthesia, age, gender and the 
amount of intravenous fluids.  
 
The incidence of POUR was 0.8% in patients at low risk of urinary retention in a study done by Pavlin et 
al (18). In Pavlin’s (18) study the definition of POUR was an inability to void at a bladder volume of more 
than 600 ml measured by ultrasound. The aim of the study was to determine whether monitoring of 
bladder volume in the recovery room by ultrasound reduced unnecessary bladder catheterisation and 
prolonged bladder overdistention compared to conventional management. The low risk category 
included patients who had low risk surgery and received a general anaesthetic, peripheral nerve blocks 
or local anaesthesia. Low risk surgery excluded hernia repair, anal or pelvic surgery. (18) 
 
A study conducted by Tammela et al. (10) compared well to our study in terms of definition of POUR and 
when patients were catheterised. In the study by Tammela et al. (10) patients were catheterised when 
they were still unable to void after non-invasive measures were instituted including encouragement to 
void, ambulation, non-opiate analgesia and privacy was given to the patient. Catheterisation was 
performed if the bladder was palpable, the patient had discomfort and pain from bladder distention or 
several hours had passed since surgery ended. The decision to catheterise a patient was made by the 
nursing staff based on the above measures. The study demonstrated an incidence of urinary retention of 
3.8% compared to an incidence of 0.6% in our study. The higher incidence in the study by Tammela et al. 
(10) can be attributed to the inclusion of patients with preoperative neurological damage, preoperative 
abnormal micturition, history of POUR, previous urinary tract surgery, urinary tract infection, raised 
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serum creatinine levels, enlarged prostate and several surgeries which were excluded in our study 
including thoracotomies, laparotomies, anal, urologic, vascular, spine, inguinal, endoprosthetic surgeries 
of hips and knees and emergency surgery. From the patients who had urinary retention, 70% received a 
general anaesthetic in the study by Tammela et al. (10) Unfortunately this study did not describe the 
methods and definitions clearly. (10) 
Although only one participant in our study had POUR, the volume of urine drained at catheterisation is a 
concern. Normal bladder capacity for an average adult is considered to be 400-600 ml (3, 4, 6). The 
participant in our study who had POUR drained 2000 ml at catheterisation after non-invasive measures 
failed. Bladder overdistention may cause significant discomfort, distress and pain and result in patient 
dissatisfaction (6, 30). In the post-operative period, patients may often be unaware of an overdistended 
bladder for several hours due to an obtunded state or decreased sensation from neuraxial anaesthesia 
or opioids (1, 4, 53). Prolonged bladder overdistention may have deleterious effects including vesico-
urethral reflux, urinary tract infection (5, 53) and irreversible damage to nerves and the postjunctional 
membrane resulting in abnormal voiding (1-5). These effects may be more pronounced in the elderly 
due to age-related changes in blood flow to the bladder and degenerative changes (2, 53). POUR and its 
adverse effects contribute to increased cost and a prolonged hospital stay (2, 6, 7). Non-invasive 
measures might have been attempted for a prolonged period in the participant in our study who had 
POUR. There is limited literature available on the recommended period that non-invasive measures can 
be attempted before it is considered to have failed. If bladder volumes were monitored in our study 
using ultrasound, the participant who had POUR would have been catheterised earlier. This could have 
prevented the discomfort and pain the participant experienced and improved patient satisfaction. The 
participant in our study who had POUR was very distressed and even requested to be sent to another 
hospital. The presence of adverse effects from prolonged bladder overdistension or catheterisation was 
beyond the scope of this study.  
 
Spinal and epidural anaesthesia are considered to be risk factors for POUR (4, 11, 18-20, 50). A neuraxial 
block eliminates sensation and blocks the micturition reflex, resulting in urinary retention (40). In this 
study only 13.5% (n=21) of participants received neuraxial anaesthesia. The anaesthetic technique, 
medication and volume of intravenous fluid used for each participant was at the discretion of the 
anaesthesiologist, registrar or medical officer managing the case and was not influenced by the 
researcher.  Considering the added risk of POUR when a patient received a neuraxial block, the 
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occurrence of POUR found in our study might have been higher if it included more patients who 
received neuraxial block. 
  
In our study all the participants who received neuraxial anaesthesia (13.5%, n=21) had a spinal 
anaesthetic with 0.5% bupivacaine, either plain or with dextrose. Of these participants 71.4% (n=15) 
received a neuraxial opioid mixed with the local anaesthetic. Fentanyl was the only opioid used in 
neuraxial anaesthesia in our study. Longer acting neuraxial anaesthetics administered intrathecally are 
associated with a higher occurrence of POUR (24, 37, 50). Neuraxial opioids result in decreased detrusor 
contractility and sensation to void which may be related to the dose and pharmacokinetics of the opioid 
used (25, 40). Patients who received intrathecal opioids may have significant residual volume after 
spontaneous voiding due to abnormal bladder function (25). Measuring residual volume after 
spontaneous voiding was beyond the scope of our study.  
 
Although the increased sympathetic stimulation associated with inadequate analgesia can lead to POUR 
(3, 9), POUR can also be attributed to opioid use (40, 41). Systemically administered opioids increase the 
risk for POUR by inhibition of parasympathetic tone (40), resulting in an increase in detrusor muscle 
tone and sphincter tone (40, 41). Multimodal analgesia is advocated in the peri-operative period to 
provide adequate analgesia. Use of the lowest effective dose of opioids are recommended (15). 
Systemic opioids were used in the peri-operative period in 98.1% (n=153) of all participants. Only 1.3% 
(n=2) of participants who received a neuraxial anaesthesia and one participant (0.6%) who received a 
general anaesthetic did not receive any systemic opioids in the peri-operative period in our study. Refer 
to Table 4.2 for the use of opioids in our study.  
 
The use of NSAIDs may result in detrusor relaxation and decreased bladder smooth muscle activity (3). 
NSAIDs were administered in 88.5% (n=138) of participants in the peri-operative period. Of these 
participants, 3.2% (n=5) received NSAIDS intraoperatively, 44.9% (n=70) in the post-operative period 
only and 40.4% (n=63) participants received NSAIDS both intra- and post-operatively (Refer to Table 
4.4).  
 
Opioids are commonly prescribed in the post-operative period together with NSAIDS at CHBAH to 
provide adequate analgesia. In our study the use of opioids and NSAIDS does not seem to have 
contributed significantly to the development of POUR. However, in the post-operative wards some 
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patients did not receive the medications at the dosing intervals as prescribed. There is a possibility that 
more patients would have developed POUR had they received the prescribed dosages of analgesia at 
the correct intervals. 
 
Several medications used by anaesthesiologists, other than opioids, are thought to potentially 
contribute to the development of POUR based on the mechanism of action. These include 
anticholinergics, calcium channel blockers, NSAIDs, β- and α-agonists, propofol, etomidate, 
benzodiazepines, barbiturates and ketamine. (3, 8, 15, 40, 41) Refer to table 4.3 for the use of these 
agents in our study sample. Barbiturates, etomidate and glycopyrrolate were not used in any of the 
participants in our study. 
 
Atropine was used in 44.0% (n=59) of participants who received a general anaesthetic in our study. 
Atropine in all of these participants was used to counteract the side-effects of neostigmine used to 
reverse the non-depolarising muscle relaxants. At the time of data collection there was a shortage of 
glycopyrrolate which is usually preferred above atropine for this purpose due to the better side-effect 
profile. Atropine was not used to treat bradycardia in any of the participants in our study. 
Anticholinergics may contribute to the development of POUR by decreasing bladder tone and increasing 
sphincter tone (15, 40, 41). Other medications with anticholinergic activity (e. g. hyoscine butylbromide, 
promethazine, ipratropium) (42, 43) were not used in any of the participants in our study. 
 
The mean age of this study sample was 36.7 years. In this study 12.8% (n=20) of participants were older 
than 50 years and from this group only 5.8% (n=9) participants were 60 years and older. Various studies 
identified age as a risk factor to POUR (4, 10-14, 50) and suggested degenerative changes to the bladder, 
benign prostatic hypertrophy and other pathologies may be responsible for the higher incidence with 
increasing age (10). In our study, participants with obstructive or irritative urinary symptoms were 
excluded.  In a study by Tammela et al. (10) the incidence of POUR  in the older age groups were 
consistent with other studies suggesting age to be a risk factor. Surprisingly the incidence of POUR 
among females between the ages of 21-40 years was also high (10). Kreutzinger et al. (13) had a similar 
results with an OR for urinary retention of 6.125 for females younger than 40 years compared to women 
between 40-60 years. A high sympathetic tone in females younger than 40 years was thought to play a 
role (10).  
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Gender as a risk factor to the development of POUR is controversial. Several studies have shown no 
significant difference between males and females (4, 11, 14) whereas other studies indicated males (10, 
12) or females (13) are at higher risk. In our study the majority of the study sample was male. Only 4.5% 
(n=7) of male participants were older than 50 years and none of them were older than 60 years. All 
participants with irritative or obstructive urinary symptoms were excluded in our study. This would have 
excluded participants with BPH and other urinary tract pathology which were thought to contribute to 
the higher incidence of POUR in other studies (8). From the females, 21.8% (n=34) were between the 
age of 21-40years, 16.7% (n=26) were older than 40 years and 1.3% (n=2) participants were younger 
than 21 years.  
 
The contribution of the amount of intravenous fluid to the development of POUR is controversial. 
Several studies stated the amount of intravenous fluid did not increase the incidence of POUR (1, 13), 
whereas other studies identified an association between POUR and large amounts of intravenous fluid 
administration (14, 37). Fluid status, including hydration status preoperatively and blood loss 
intraoperatively, was not assessed in our study. The mean intravenous fluid volume administered was 
947.88 ml (SD 502.8). The documentation of intravenous fluid administered intraoperatively may have 
been done inaccurately. A request was made in the weekly e-mail of the anaesthetic department of 
CHBAH at commencement of data collection to document the amount of intravenous fluid administered 
during the intraoperative period accurately and clearly on the anaesthetic chart. Despite the request no 
intravenous fluid volume was documented on 9.0% (n=14) of participants’ anaesthetic charts. A number 
of anaesthesia providers may have recorded the volume of the vaculitre used and not the actual amount 
of fluid administered. This is suspected since  64.7% (n=101) of participants had intravenous fluid 
recorded as either 1000 or 2000 ml. Considering  the possibility that anaesthetic providers may have 
documented the volume of the vaculitre and 9.0% (n=14) of participants had no volume recorded, the 
recorded volume of intravenous fluid administered to 73.7% (n=115) participants may have been 
inaccurate. Therefore in this study it is not possible to comment whether fluid administration was 
excessive or not. 
 
In our study participants were not encouraged to void immediately preoperatively and whether 
participants voided preoperatively were not documented. Patients who did not void prior to transport 
to theatre or with bladder volumes of 100-270 ml prior to induction of anaesthesia were associated with 
POUR in several studies (11, 14, 20). Even when patients void before transport to theatre, they may 
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have a significant residual volume which can be attributed to pain, immobility and the use of opioids in 
the preoperative period and even if they do not have a residual volume, they may have distended 
bladders at the time of induction (54). Bladder volumes of 300-500ml post-operatively were identified as 
an indicator of POUR (6, 20, 47).  
 
Various studies have identified the inability to mobilise as a predisposing factor for POUR (10, 13, 41). 
The ability to mobilise post-operatively was not documented in our study. 
 
The use of ultrasound has been advocated by various studies to guide decision making regarding urinary 
catheterisation (1, 4, 11, 18, 20, 23). Ultrasound measurement of bladder volume is a quick, non-
invasive and an accurate manner to diagnose POUR (5, 9, 13, 18, 23) with no or very little discomfort to 
the patient (9, 20). The use of ultrasound can assist in the early diagnosis of POUR and therefore prevent 
severe discomfort, pain and other effects of POUR to patients. The limitations related to ultrasound use 
for the diagnosis of POUR include the initial cost to purchase, training and availability of trained staff (9) 
and the lack of a standard bladder volume on ultrasound to make the diagnosis of POUR. The bladder 
volumes used in studies ranged between 300-600ml (1, 5, 8, 11). The BladderScan BVI 3000™ is an 
ultrasound machine that is easy to use, portable and battery operated. It allows an assessment of 
bladder volume by the press of a button therefore minimal training is needed to asses bladder volume 
accurately. It displays the volume of the bladder in millilitres on the LCD screen and no image 
interpretation is needed. (56) Studies have demonstrated operator and patient satisfaction with these 
portable ultrasound devices (55).  At CHBAH there is no BladderScan BVI 3000™ or a similar easy to use 
ultrasound machine available. It was also not possible to have a dedicated ultrasound machine available 
to measure bladder volumes at the time of the study and none of the staff in the anaesthesia 
department are trained to measure bladder volumes. There is one ultrasound machine available in 
theatre which is used for peripheral nerve blocks on a daily basis. It is possible that the occurrence of 
POUR in our study might have been higher if POUR was diagnosed using a bladder volume on 
ultrasound.  
 
The findings of our study were not what were expected as the perception was that the occurrence of 
POUR in low risk patients at CHBAH was at least 25%. The perception that the occurrence of POUR may 
be high at CHBAH could be contributed to cognitive errors, also referred to as Cognitive Dispositions to 
Respond (CDR). A number of CDRs exist but two types are applicable in this scenario, Availability CDR 
64 
 
and Base-rate neglect CDR. Availability CDR refer to a situation where a clinician perceives a diagnosis to 
occur frequently or to be very likely if it readily comes to mind. The clinician’s diagnosis or thoughts are 
influenced by recent situations or experiences. Base-rate neglect refers to increasing or decreasing the 
true prevalence of a disease. The clinician may not be aware of the CDR influencing his/her thoughts and 
decisions. (63) 
 
The low occurrence of POUR places this study in the so-called “negative research” category, however, 
the researcher is of the opinion that the results from this study do contribute to the body of knowledge 
regarding POUR in low risk surgical patients at CHBAH. Internationally there is a tendency not to analyse 
or publish negative or non-significant results (64). There are various reasons for not publishing negative 
research for example: 
• the inclination of journals to only publish research with significant positive findings 
(65, 66), 
• pressure to publish in order to get funds for research force researchers into a 
direction of research where significant positive findings are more likely (66), and 
• fear of a bad reputation associated with negative results (65-67) 
 
This reporting and publication bias contributes to an imbalance of information available to clinicians on 
which they base clinical decisions. Publication of negative results can correct the existing imbalance and 
add value by encouraging good research practice, direct further research, minimise duplicate work, 
improved transparency, reveal common flaws in research methods used and improve clinical decision 
making. (65-70) 
 
Publication of negative research results also forces the researcher and clinicians to re-evaluate personal 
preconceptions and thought processes. The value of reporting has been increasingly recognised. In 
recent years several journals were established in which studies with non-significant findings can be 
published in an attempt to eliminate or minimise the negative attitude toward these studies. These 
journals include The Journal of Negative Results in Biomedicine, The All Results Journal and The Journal 
of Articles in Support of the Null Hypothesis. (66, 69) 
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4.4 Conclusion 
 
The occurrence of POUR in this study was 0.64% (n=1). Possible contributing factors to POUR in this 
participant were 35 year old female, 2000ml intravenous fluid, and the use of opioids, propofol, atropine 
and NSAIDs. The volume of urine drained on catheterisation of 2000ml is a concern as this is 3.5-5 times 
normal bladder capacity. This study could not determine whether the occurrence of POUR was 
influenced by age or gender. 
 
4.5 Summary 
 
This chapter dealt with the results and discussion of results of the data collected for the research report, 
according to the primary and secondary objectives of this study. The data presented included the 
occurrence of POUR in patients at low risk who present for elective surgery, the volume of urine drained 
on catheterisation, the type of anaesthetic technique, medications administered and whether the 
occurrence of POUR was influenced by age and gender. 
 
In the final chapter a summary, the limitations, recommendations and conclusions of the study are 
presented. 
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CHAPTER FIVE 
SUMMARY, LIMITATIONS, RECOMMENDATIONS, 
CONCLUSION 
 
5.1 Introduction 
 
In this chapter a summary of the study, the limitations, recommendations for clinical practice and 
further research and a conclusion are presented.   
 
5.2 Summary of the study  
 
5.2.1 The aim of the study 
 
The aim of this study was to describe the occurrence of POUR in adult patients at low risk of POUR who 
presented for elective surgical procedures at CHBAH and to determine if this was influenced by age, 
gender or type of anaesthetic received.   
 
5.2.2 Objectives of the study 
 
The primary objective of this study was to describe the occurrence of POUR in low risk patients following 
elective surgical procedures. 
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The secondary objectives of this study were to: 
• determine if the occurrence of POUR was influenced by: 
• the type of anaesthetic  
• the age of the patient  
• the gender of the patient 
• describe the medications administered in the peri-operative period. 
 
5.2.3 Summary of the methodology used in the study 
 
A prospective, contextual, descriptive study design was used. This study described the occurrence of 
POUR in patients who presented for surgery at CHBAH and were at low risk for POUR.  
The population for this study was adult patients in the post-operative wards who were at low risk for 
POUR and received either general anaesthesia or a neuraxial block during their elective surgical 
procedure. The patients were booked for elective procedures in orthopaedic, general surgery, ENT, 
maxillo-facial, plastic and ophthalmology.  
In consultation with a biostatistician a sample size of 150 participants was calculated using the program 
nQuery Advisor. From a sample size of 150 patients we can expect 25% to have POUR to an accuracy of 
7% with 95% confidence 
In this study a convenience sampling method was used. Readily available participants were invited to 
participate in the study until the sample size (n=150) was realised. 
Potential participants from the specified surgical disciplines were identified from the theatre booking 
lists in the CHBAH J.D. Allen Theatre Complex the day before surgery or on the day of surgery but before 
the patient arrived in theatre from the ward. 
 
The participants were approached in their respective wards before surgery. An information letter 
(Appendix A) was given to each participant and the researcher explained the purpose of the study. If the 
patient agreed to participate in the study, written informed consent (Appendix B) was obtained from the 
participant. 
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The researcher approached participants 12 – 24 hours following surgery and collected the following 
information from the participant, the anaesthetic record and the participant’s file using the data capture 
sheet (Appendix C):  
• age 
• gender 
• type of surgery 
• length of procedure 
• type of anaesthetic  
• ability to void spontaneously or catheterised since admission to the ward following surgery 
• non-invasive interventions done by the nursing staff if the participant was not able to void 
spontaneously 
• if the participant was catheterised, documented volume and whether in-out or indwelling 
catheterisation was done 
• amount of peri-operative fluids administered 
• medications received peri-operatively. 
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Participants were excluded if they had one or more of the following: 
• Participants with a previous history of POUR or any urinary tract related problems including: 
o nocturia 
o frequency 
o urgency 
o hesitancy  
o incontinence 
o weak stream 
o dysuria  
o known BPH or other prostate pathology 
o urinary tract infection within the last week 
• known diagnosis of renal failure 
• indwelling urinary catheter in situ 
• catheterisation (in-out or indwelling) during the surgical procedure  
• no intravenous fluid administered peri-operatively  
• hyperglycemia 
• diuretic use 
• surgery considered to be high risk for POUR or including pelvic surgery, anorectal surgery, 
inguinal hernia repair, spine surgery, neurosurgery, arthroplasty  
• known neurologic pathology 
• continuous epidural anaesthesia or analgesia 
A few participants were also excluded due to communication difficulty, refusal to participate, early 
discharge, cancellation of surgery and no neuraxial or general anaesthetic administered for the 
participant’s procedure. 
 
5.2.4 Main Findings of the study 
 
In our study only one participant (0.64%) from the 156 participants had POUR. This participant was a 35 
year old female who had general surgery under general anaesthesia.  Opioids, propofol, atropine and 
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NSAIDs were administered in the peri-operative period. The retention volume drained at catheterisation 
was 2000 ml after non-invasive measures failed. Our study could not determine whether POUR was 
influenced by the type of anaesthetic, age or gender. Multimodal analgesia is used at CHBAH in the peri-
operative period as evident by the high number of participants who received opioids and NSAIDs. 
 
5.3 Limitations of the study  
 
The potential limitations to this study included the following: 
The contextual nature of the study means that the result represent the occurrence of POUR in patients 
who were at low risk for POUR at CHBAH and may not be generalisable to patients in other settings. 
Many other factors influence the occurrence of POUR such as the amount of fluid given peri-operatively, 
comorbidities, whether the patient voided shortly before surgery commenced and whether the patient 
was mobilised early or not. Identification of all these factors was, however, beyond the scope of this 
study. 
Participants were recruited at the convenience of the researcher. 
The assessment of non-invasive measures done was based on the participant’s awareness and 
understanding of the nurses actions.  
There is a possibility that the amount of intravenous fluid received peri-operatively may not be 
documented accurately. The anaesthetic team at CHBAH was requested to document the amount of 
intravenous fluid administered accurately and clearly on the anaesthetic chart. Despite this, several 
anaesthetic records had no volume of intravenous fluid documented. An assessment of the peri-
operative hydration status of the participant and documentation of blood loss intra-operative were not 
done in this study. 
Fluid balance of the participants was not assessed. 
Documentation of the volume of urine drained at first catheterisation was done by the nurse looking 
after the participant for the particular shift in the respective ward. It is possible that the nurse did not 
document the volume of urine accurately. 
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In this study the residual volume of urine after spontaneous voiding was not measured. 
It is beyond the scope of this study to comment on complications evolving from prolonged bladder 
distension and urinary catheterisation.  
It is possible that the occurrence of POUR at CHBAH would have been higher if the study sample 
consisted of more participants who received neuraxial anaesthesia, ultrasound was used to diagnose 
POUR or less stringent exclusion criteria was used.  
 
Although the majority of participants received opioids in the post-operative wards, the opioids were not 
administered as prescribed for all the participants e. g. nursing staff did not adhere to the dosing 
intervals. It is possible that the occurrence of POUR at CHBAH would have been higher if participants 
received the opioids as prescribed. 
 
5.4 Recommendations from the study 
  
5.4.1 Recommendations for clinical practice 
 
Many risk factors for POUR are non-modifiable and unavoidable and a high index of suspicion for POUR 
should be applied to all patients presenting for surgery. A thorough history should be obtained from all 
patients preoperatively including voiding history.  
 
A definition for POUR should be agreed upon at CHBAH since an internationally recognised definition of 
POUR does not exist and the diagnosis of POUR depends on the definition used. The definition used at 
CHBAH will have to be based on clinical recognition or time. A diagnosis based on clinical recognition or 
time is not ideal but ultrasound for the diagnosis of POUR is currently not readily available at CHBAH. 
 
A protocol for the recognition and appropriate management of POUR is recommended to avoid 
prolonged bladder overdistention. The participant in our study who had POUR drained 2000 ml on 
urinary catheterisation after non-invasive management had failed. The protocol should include risk 
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factors, the time period thought to be appropriate for non-invasive measures, when to catheterise and 
whether antibiotics are indicated when a patient is catheterised.  
 
5.4.2 Recommendations for further research 
  
The development of a precise unambiguous definition of POUR that is recognised internationally would 
aid in the development of an evidence-based guideline on prevention and management of POUR. 
Current literature is difficult to compare due to a variety of definitions used for POUR. 
 
The likelihood of POUR based on the number of risk factors present in a patient could be investigated 
and possibly incorporated into a protocol. Further research could facilitate the development of a 
protocol for the prevention, diagnosis and management of POUR.  
 
In our study we used very stringent criteria to investigate the occurrence of POUR in patients at low risk. 
Another study at CHBAH with less stringent criteria is recommended to describe the occurrence of POUR 
in patients at higher risk.  
 
The use of ultrasound to diagnose POUR has gained popularity. Unfortunately these devices are not 
available at CHBAH. When ultrasound becomes more readily available at CHBAH further studies using 
ultrasound to diagnose POUR is recommended.  
 
Further research to assess patient satisfaction at CHBAH is recommended. This could aid in the 
identification of areas of improvement and possible further research.   
 
 
5.5 Conclusion  
 
The occurrence of POUR in patients at low risk at CHBAH is low. This study could not determine whether 
POUR was influenced by type of anaesthetic , age or gender. Multimodal anaesthesia is commonly used 
at CHBAH in the peri-operative period.  
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5.6 Summary  
 
In this chapter a summary of the study, the limitations, recommendations for clinical practice and 
further research and a conclusion were presented.   
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APPENDIX A:1PARTICIPANT INFORMATION LETTER 
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APPENDIX B:2INFORMED CONSENT 
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APPENDIX C:3DATA CAPTURE SHEET  
 
Pre-operative:    
History of POUR YES NO 
Nocturia YES NO 
Frequency  YES NO 
Urgency YES NO 
Hesitancy YES NO 
Incontinence YES NO 
Weak Stream YES NO 
Dysuria  YES NO 
BPH/Prostate pathology YES NO 
Urinary Tract Infection within the last week YES NO 
Renal Failure YES NO 
Indwelling Urinary Catheter In Situ YES NO 
Hyperglycaemia YES NO 
Diuretic use YES NO 
Surgery Considered to be High Risk for POUR including pelvic surgery, anorectal surgery, inguinal hernia repair, spine 
surgery, neurosurgery  
YES NO 
Neurologic Pathology YES NO 
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Post-operative 
Catheterisation intra-operatively (in-out or indwelling) YES NOI 
Hyperglycaemia YES NO 
Diuretic use YES NO 
Continuous Epidural Anaesthesia or Analgesia YES NO 
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1. Demographics 
 
Study number  
 
Male  
Female  
 
Age  
 
2. Surgery 
 
ENT  
General surgery  
Maxillo-Facial  
Orthopedic  
Other  
 
Length of the procedure Hours  
 Minutes  
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Volume of IV fluid received intra-operatively  
 
General anaesthesia  
Neuraxial block   
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3. Post-operative  
 
Was patient able to void spontaneously? Yes  
 No  
 
 
If no, was any non-invasive intervention undertaken? Yes  
 No  
 
If yes indicate intervention(s) Encouraged to void  
 Audible running water close to the patient  
 Place patient’s hand in hot water  
Allow patient to have a hot bath  
 Encourage patient to sit, stand or early ambulation  
Minimise post-operative discomfort  
 IV fluid bolus  
Other  
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Was patient catheterised? Yes  
 No  
 
If the patient was catheterised was it: In-out catheterisation  
 Indwelling catheter  
 
 
Retention volume drained at catheterisation?  
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4. Classes peri-operative medication received 
 
 Systemic NAB 
Opioids   
Benzodiazepines   
Propofol   
Etomidate   
Ketamine   
Barbiturate   
Anticholinergics   
β-Adrenergic agonists   
α-Adrenergic agonists   
β-Adrenergic antagonists   
Calcium channel antagonist    
NSAIDs   
Local anaesthetic   
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APPENDIX D:4PERMISSION FROM POST-GRADUATE 
COMMITTEE 
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APPENDIX E:5APPROVAL FROM ETHICS COMMITTEE 
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APPENDIX F:6APPROVAL FROM THE MEDICAL 
ADVISORY COMMITTEE AT CHBAH
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